QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
| |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) | |
|
|
|
, |
| |
(Address of principal executive offices) |
(Zip Code) |
|
☒ |
Accelerated filer |
☐ | ||
Non-accelerated filer |
☐ |
Smaller reporting company |
| ||
Emerging growth company |
|
Title of Each Class |
Trading Symbol |
Name of each exchange on which registered | ||
|
|
|
Page |
||||||
Item 1. |
3 |
|||||
3 |
||||||
4 |
||||||
5 |
||||||
6 |
||||||
7 |
||||||
8 |
||||||
Item 2. |
67 |
|||||
Item 3. |
140 |
|||||
Item 4. |
140 |
|||||
141 |
||||||
Item 1. |
141 |
|||||
Item 1A. |
141 |
|||||
Item 6. |
142 |
|||||
143 |
March 31, 2020 |
December 31, 2019 |
|||||||
(Unaudited) |
||||||||
Assets |
||||||||
Investments: |
||||||||
Fixed maturity securities available-for-sale, at fair value (amortized cost of $ |
$ | |
$ | |
||||
Equity securities, at fair value |
|
|
||||||
Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $ |
|
|
||||||
Less: Allowance for credit losses |
( |
) | ( |
) | ||||
Commercial mortgage loans, net |
|
|
||||||
Policy loans |
|
|
||||||
Other invested assets |
|
|
||||||
Total investments |
|
|
||||||
Cash, cash equivalents and restricted cash |
|
|
||||||
Accrued investment income |
|
|
||||||
Deferred acquisition costs |
|
|
||||||
Intangible assets and goodwill |
|
|
||||||
Reinsurance recoverable |
|
|
||||||
Less: Allowance for credit losses |
( |
) | — |
|||||
Reinsurance recoverable, net |
|
|
||||||
Other assets |
|
|
||||||
Deferred tax asset |
|
|
||||||
Separate account assets |
|
|
||||||
Total assets |
$ | |
$ | |
||||
Liabilities and equity |
||||||||
Liabilities: |
||||||||
Future policy benefits |
$ | |
$ | |
||||
Policyholder account balances |
|
|
||||||
Liability for policy and contract claims |
|
|
||||||
Unearned premiums |
|
|
||||||
Other liabilities |
|
|
||||||
Non-recourse funding obligations |
— |
|
||||||
Long-term borrowings |
|
|
||||||
Separate account liabilities |
|
|
||||||
Total liabilities |
|
|
||||||
Commitments and contingencies |
||||||||
Equity: |
||||||||
Class A common stock, $ |
|
|
||||||
Additional paid-in capital |
|
|
||||||
Accumulated other comprehensive income (loss) |
|
|
||||||
Retained earnings |
|
|
||||||
Treasury stock, at cost ( |
( |
) | ( |
) | ||||
Total Genworth Financial, Inc.’s stockholders’ equity |
|
|
||||||
Noncontrolling interests |
|
|
||||||
Total equity |
|
|
||||||
Total liabilities and equity |
$ | |
$ | |
||||
Three months ended March 31, |
||||||||
2020 |
2019 |
|||||||
Revenues: |
||||||||
Premiums |
$ |
|
$ |
|
||||
Net investment income |
|
|
||||||
Net investment gains (losses) |
( |
) |
|
|||||
Policy fees and other income |
|
|
||||||
Total revenues |
|
|
||||||
Benefits and expenses: |
||||||||
Benefits and other changes in policy reserves |
|
|
||||||
Interest credited |
|
|
||||||
Acquisition and operating expenses, net of deferrals |
|
|
||||||
Amortization of deferred acquisition costs and intangibles |
|
|
||||||
Interest expense |
|
|
||||||
Total benefits and expenses |
|
|
||||||
Income (loss) from continuing operations before income taxes |
( |
) |
|
|||||
Provision (benefit) for income taxes |
( |
) |
|
|||||
Income (loss) from continuing operations |
( |
) |
|
|||||
Income from discontinued operations, net of taxes |
— |
|
||||||
Net income (loss) |
( |
) |
|
|||||
Less: net income (loss) from continuing operations attributable to noncontrolling interests |
( |
) |
|
|||||
Less: net income from discontinued operations attributable to noncontrolling interests |
— |
|
||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ |
( |
) |
$ |
|
|||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders: |
||||||||
Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders |
( |
) |
|
|||||
Income from discontinued operations available to Genworth Financial, Inc.’s common common stockholders |
— |
|
||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ |
( |
) |
$ |
|
|||
Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||
Basic |
$ |
( |
) |
$ |
|
|||
Diluted |
$ |
( |
) |
$ |
|
|||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||
Basic |
$ |
( |
) |
$ |
|
|||
Diluted |
$ |
( |
) |
$ |
|
|||
Weighted-average common shares outstanding: |
||||||||
Basic |
|
|
||||||
Diluted |
|
|
||||||
Three months ended March 31, |
||||||||
2020 |
2019 |
|||||||
Net income (loss) |
$ ( |
) | $ |
|||||
Other comprehensive income (loss), net of taxes: |
||||||||
Net unrealized gains (losses) on securities without an allowance for credit losses |
( |
) | — |
|||||
Net unrealized gains (losses) on securities with an allowance for credit losses |
— |
— |
||||||
Net unrealized gains (losses) on securities not other-than-temporarily impaired |
— |
|
||||||
Net unrealized gains (losses) on other-than-temporarily impaired securities |
|
|
||||||
Derivatives qualifying as hedges |
|
|
||||||
Foreign currency translation and other adjustments |
( |
) | |
|||||
Total other comprehensive income (loss) |
|
|
||||||
Total comprehensive income |
|
|
||||||
Less: comprehensive income (loss) attributable to noncontrolling interests |
( |
) | |
|||||
Total comprehensive income available to Genworth Financial, Inc.’s common stockholders |
$ |
$ |
||||||
Three months ended March 31, 2020 |
||||||||||||||||||||||||||||||||
Common stock |
Additional paid-in capital |
Accumulated other comprehensive income (loss) |
Retained earnings |
Treasury stock, at cost |
Total Genworth Financial, Inc.’s stockholders’ equity |
Noncontrolling interests |
Total equity |
|||||||||||||||||||||||||
Balances as of December 31, 2019 |
$ | |
$ | |
$ | |
$ | |
$ | ( |
$ | |
$ | |
$ | |
||||||||||||||||
Cumulative effect of change in accounting, net of taxes |
— |
— |
— |
( |
) | — |
( |
) | — |
( |
) | |||||||||||||||||||||
Comprehensive income (loss): |
||||||||||||||||||||||||||||||||
Net loss |
— |
— |
— |
( |
) | — |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||
Other comprehensive income (loss), net of taxes |
— |
— |
|
— |
— |
|
( |
) | |
|||||||||||||||||||||||
Total comprehensive income (loss) |
|
( |
) | |
||||||||||||||||||||||||||||
Dividends to noncontrolling interests |
— |
— |
— |
— |
— |
— |
( |
) | ( |
) | ||||||||||||||||||||||
Stock-based compensation expense and exercises and other |
— |
|
— |
— |
— |
|
— |
|
||||||||||||||||||||||||
Balances as of March 31, 2020 |
$ | |
$ | |
$ | |
$ | |
$ | ( |
) | $ | |
$ | |
$ |
|
|||||||||||||||
Three months ended March 31, 2019 |
||||||||||||||||||||||||||||||||
Common stock |
Additional paid-in capital |
Accumulated other comprehensive income (loss) |
Retained earnings |
Treasury stock, at cost |
Total Genworth Financial, Inc.’s stockholders’ equity |
Noncontrolling interests |
Total equity |
|||||||||||||||||||||||||
Balances as of December 31, 2018 |
$ | |
$ | |
$ | |
$ | |
$ | ( |
) | $ | |
$ | |
$ | |
|||||||||||||||
Repurchase of subsidiary shares |
— |
— |
— |
— |
— |
— |
( |
) | ( |
) | ||||||||||||||||||||||
Comprehensive income: |
||||||||||||||||||||||||||||||||
Net income |
— |
— |
— |
|
— |
|
|
|
||||||||||||||||||||||||
Other comprehensive income, net of taxes |
— |
— |
|
— |
— |
|
|
|
||||||||||||||||||||||||
Total comprehensive income |
|
|
|
|||||||||||||||||||||||||||||
Dividends to noncontrolling interests |
— |
— |
— |
— |
— |
— |
( |
) | ( |
) | ||||||||||||||||||||||
Stock-based compensation expense and exercises and other |
— |
|
— |
— |
— |
|
( |
) | — |
|||||||||||||||||||||||
Balances as of March 31, 2019 |
$ | |
$ | |
$ | |
$ | |
$ | ( |
) | $ | |
$ | |
$ |
|
|||||||||||||||
|
Three months ended March 31, |
|||||||
2020 |
2019 |
|||||||
Cash flows from operating activities: |
||||||||
Net income (loss) |
$ | ( |
) | $ | |
|||
Less income from discontinued operations, net of taxes |
— |
( |
) | |||||
Adjustments to reconcile net income (loss) to net cash from operating activities: |
||||||||
Amortization of fixed maturity securities discounts and premiums |
( |
) | ( |
) | ||||
Net investment (gains) losses |
|
( |
) | |||||
Charges assessed to policyholders |
( |
) | ( |
) | ||||
Acquisition costs deferred |
( |
) | ( |
) | ||||
Amortization of deferred acquisition costs and intangibles |
|
|
||||||
Deferred income taxes |
( |
) | |
|||||
Derivative instruments, limited partnerships and other |
|
( |
) | |||||
Stock-based compensation expense |
|
|
||||||
Change in certain assets and liabilities: |
||||||||
Accrued investment income and other assets |
( |
) | ( |
) | ||||
Insurance reserves |
|
|
||||||
Current tax liabilities |
( |
) | |
|||||
Other liabilities, policy and contract claims and other policy-related balances |
|
|
||||||
Cash from operating activities—discontinued operations |
— |
|
||||||
Net cash from operating activities |
|
|
||||||
Cash flows from (used by) investing activities: |
||||||||
Proceeds from maturities and repayments of investments: |
||||||||
Fixed maturity securities |
|
|
||||||
Commercial mortgage loans |
|
|
||||||
Other invested assets |
|
|
||||||
Proceeds from sales of investments: |
||||||||
Fixed maturity and equity securities |
|
|
||||||
Purchases and originations of investments: |
||||||||
Fixed maturity and equity securities |
( |
) | ( |
) | ||||
Commercial mortgage loans |
( |
) | ( |
) | ||||
Other invested assets |
( |
) | ( |
) | ||||
Short-term investments, net |
|
|
||||||
Policy loans, net |
|
|
||||||
Cash used by investing activities—discontinued operations |
— |
( |
) | |||||
Net cash from (used by) investing activities |
( |
) | |
|||||
Cash flows used by financing activities: |
||||||||
Deposits to universal life and investment contracts |
|
|
||||||
Withdrawals from universal life and investment contracts |
( |
) | ( |
) | ||||
Redemption of non-recourse funding obligations |
( |
) | — |
|||||
Repayment and repurchase of long-term debt |
( |
) | — |
|||||
Repurchase of subsidiary shares |
— |
( |
) | |||||
Dividends paid to noncontrolling interests |
( |
) | ( |
) | ||||
Other, net |
|
|
||||||
Cash used by financing activities—discontinued operations |
— |
( |
) | |||||
Net cash used by financing activities |
( |
) | ( |
) | ||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash (includes $ |
( |
) | |
|||||
Net change in cash, cash equivalents and restricted cash |
( |
) | |
|||||
Cash, cash equivalents and restricted cash at beginning of period |
|
|
||||||
Cash, cash equivalents and restricted cash at end of period |
|
|
||||||
Less cash, cash equivalents and restricted cash of discontinued operations at end of period |
— |
|
||||||
Cash, cash equivalents and restricted cash of continuing operations at end of period |
$ | |
$ | |
||||
• | U.S. Mortgage Insurance. |
• | Australia Mortgage Insurance. |
• | U.S. Life Insurance. |
• | Runoff. |
• | assumptions will no longer be locked-in at contract inception and all cash flow assumptions used to estimate the liability for future policy benefits (except the discount rate) will be reviewed at least annually in the same period each year or more frequently if actual experience indicates a change is required. Changes will be recorded in net income (loss) using a retrospective approach with a cumulative catch-up adjustment by recalculating the net premium ratio (which will be capped at 100%) using actual historical and updated future cash flow assumptions; |
• | the discount rate used to determine the liability for future policy benefits will be a current upper-medium grade (low credit risk) fixed-income instrument yield, which is generally interpreted to mean a single-A rated bond rate for the same duration, and is required to be reviewed quarterly, with changes in the discount rate recorded in other comprehensive income (loss); |
• | the provision for adverse deviation and the premium deficiency test will be eliminated; |
• | market risk benefits associated with deposit-type contracts will be measured at fair value with changes related to instrument-specific credit risk recorded in other comprehensive income (loss) and remaining changes recorded in net income (loss); |
• | the amortization method for DAC will generally be on a straight-line basis over the expected contract term; and |
• | disclosures will be greatly expanded to include significant assumptions and product liability rollforwards. |
Three months March 31, |
||||||||
(Amounts in millions, except per share amounts) |
2020 |
2019 |
||||||
Weighted-average shares used in basic earnings (loss) per share calculations |
|
|
||||||
Potentially dilutive securities: |
||||||||
Stock options, restricted stock units and stock appreciation rights |
|
|
||||||
Weighted-average shares used in diluted earnings (loss) per share calculations (1) |
|
|
||||||
Income (loss) from continuing operations: |
||||||||
Income (loss) from continuing operations |
$ | ( |
) | $ |
|
|||
Less: net income (loss) from continuing operations attributable to noncontrolling interests |
( |
) | |
|||||
Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders |
$ | ( |
) | $ | |
|||
Basic per share |
$ | ( |
) | $ | |
|||
Diluted per share |
$ | ( |
) | $ | |
|||
Income from discontinued operations: |
||||||||
Income from discontinued operations, net of taxes |
$ |
|
$ | |
||||
Less: net income from discontinued operations attributable to noncontrolling interests |
|
|
||||||
Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders |
$ | |
$ | |
||||
Basic per share |
$ | |
$ | |
||||
Diluted per share |
$ | |
$ | |
||||
Net income (loss): |
||||||||
Income (loss) from continuing operations |
$ | ( |
) | $ | |
|||
Income from discontinued operations, net of taxes |
|
|
||||||
Net income (loss) |
( |
) | |
|||||
Less: net income (loss) attributable to noncontrolling interests |
( |
) | |
|||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | ( |
) | $ | |
|||
Basic per share (2) |
$ | ( |
) | $ | |
|||
Diluted per share |
$ | ( |
) | $ | |
(1) |
Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.’s common stockholders for the three months ended March 31, 2020, we were required to use basic weighted-average common shares outstanding as the inclusion of shares for stock options, restricted stock units and stock appreciation rights of |
(2) |
May not total due to whole number calculation. |
Three months ended March 31, |
||||||||
(Amounts in millions) |
2020 |
2019 |
||||||
Fixed maturity securities—taxable |
$ | $ | ||||||
Fixed maturity securities—non-taxable |
||||||||
Equity securities |
||||||||
Commercial mortgage loans |
||||||||
Policy loans |
||||||||
Other invested assets |
||||||||
Cash, cash equivalents, restricted cash and short-term investments |
||||||||
Gross investment income before expenses and fees |
||||||||
Expenses and fees |
( |
) | ( |
) | ||||
Net investment income |
$ | $ | ||||||
Three months ended March 31, |
||||||||
(Amounts in millions) |
2020 |
2019 |
||||||
Available-for-sale fixed maturity securities: |
||||||||
Realized gains |
$ | $ | ||||||
Realized losses |
( |
) | ( |
) | ||||
Net realized gains (losses) on available-for-sale fixed maturity securities |
||||||||
Impairments: |
||||||||
Total other-than-temporary impairments |
||||||||
Portion of other-than-temporary impairments included in othercomprehensive income |
||||||||
Net other-than-temporary impairments |
||||||||
Net change in allowance for credit losses on available-for-sale fixed maturity |
||||||||
Net realized gains (losses) on equity securities sold |
||||||||
Net unrealized gains (losses) on equity securities still held |
( |
) | ||||||
Limited partnerships |
( |
) | ||||||
Commercial mortgage loans |
( |
) | ||||||
Derivative instruments (1) |
( |
) | ( |
) | ||||
Other |
( |
) | ||||||
Net investment gains (losses) |
$ | ( |
) | $ | ||||
(1) |
See note 5 for additional information on the impact of derivative instruments included in net investment gains (losses). |
(Amounts in millions) |
||||
Beginning balance |
$ | |||
Other-than-temporary impairments not previously recognized |
||||
Increases related to other-than-temporary impairments previously recognized |
||||
Reductions: |
||||
Securities sold, paid down or disposed |
( |
) | ||
Ending balance |
$ | |||
(Amounts in millions) |
March 31, 2020 |
December 31, 2019 |
||||||
Net unrealized gains (losses) on fixed maturity securities without an allowance for credit losses (1) |
$ |
$ |
||||||
Net unrealized gains (losses) on fixed maturity securities with an allowance for credit losses (1) |
||||||||
Adjustments to deferred acquisition costs, present value of future profits, sales inducements |
( |
) | ( |
) | ||||
Income taxes, net |
( |
) | ( |
) | ||||
Net unrealized investment gains (losses) |
||||||||
Less: net unrealized investment gains (losses) attributable to noncontrolling interests |
||||||||
Net unrealized investment gains (losses) attributable to Genworth Financial, Inc. |
$ |
$ |
||||||
(1) |
Excludes foreign exchange. |
(Amounts in millions) |
2020 |
2019 |
||||||
Beginning balance |
$ |
|
$ |
|
||||
Unrealized gains (losses) arising during the period: |
||||||||
Unrealized gains (losses) on fixed maturity securities |
( |
) | |
|||||
Adjustment to deferred acquisition costs |
|
( |
) | |||||
Adjustment to present value of future profits |
( |
) | ( |
) | ||||
Adjustment to sales inducements |
|
( |
) | |||||
Adjustment to benefit reserves |
|
( |
) | |||||
Provision for income taxes |
|
( |
) | |||||
Change in unrealized gains (losses) on investment securities |
( |
) | |
|||||
Reclassification adjustments to net investment (gains) losses, net of taxes of $ |
( |
) | ( |
) | ||||
Change in net unrealized investment gains (losses) |
( |
) | |
|||||
Less: change in net unrealized investment gains (losses) attributable to noncontrolling interests |
( |
) | |
|||||
Ending balance |
$ |
|
$ |
|
||||
(Amounts in millions) |
Amortized cost or cost |
Gross unrealized gains |
Gross unrealized losses |
Allowance for credit losses |
Fair value |
|||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||
State and political subdivisions |
|
|
( |
) | |
|
||||||||||||||
Non-U.S. government |
|
|
( |
) | |
|
||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
|
|
( |
) | |
|
||||||||||||||
Energy |
|
|
( |
) | |
|
||||||||||||||
Finance and insurance |
|
|
( |
) | |
|
||||||||||||||
Consumer—non-cyclical |
|
|
( |
) | |
|
||||||||||||||
Technology and communications |
|
|
( |
) | |
|
||||||||||||||
Industrial |
|
|
( |
) | |
|
||||||||||||||
Capital goods |
|
|
( |
) | |
|
||||||||||||||
Consumer—cyclical |
|
|
( |
) | |
|
||||||||||||||
Transportation |
|
|
( |
) | |
|
||||||||||||||
Other |
|
|
( |
) | |
|
||||||||||||||
Total U.S. corporate |
|
|
( |
) | |
|
||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
|
|
( |
) | |
|
||||||||||||||
Energy |
|
|
( |
) | |
|
||||||||||||||
Finance and insurance |
|
|
( |
) | |
|
||||||||||||||
Consumer—non-cyclical |
|
|
( |
) | |
|
||||||||||||||
Technology and communications |
|
|
( |
) | |
|
||||||||||||||
Industrial |
|
|
( |
) | |
|
||||||||||||||
Capital goods |
|
|
( |
) | |
|
||||||||||||||
Consumer—cyclical |
|
|
( |
) | |
|
||||||||||||||
Transportation |
|
|
( |
) | |
|
||||||||||||||
Other |
|
|
( |
) | |
|
||||||||||||||
Total non-U.S. corporate |
|
|
( |
) | |
|
||||||||||||||
Residential mortgage-backed |
|
|
( |
) | |
|
||||||||||||||
Commercial mortgage-backed |
|
|
( |
) | |
|
||||||||||||||
Other asset-backed |
|
|
( |
) | |
|
||||||||||||||
Total available-for-sale fixed maturity securities |
$ | |
$ | |
$ | ( |
) | $ | |
$ |
|
|||||||||
Gross unrealized gains |
Gross unrealized losses |
|||||||||||||||||||||||
(Amounts in millions) |
Amortized cost or cost |
Not other-than- temporarily impaired |
Other-than- temporarily impaired |
Not other-than- temporarily impaired |
Other-than- temporarily impaired |
Fair value |
||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
State and political subdivisions |
( |
) | ||||||||||||||||||||||
Non-U.S. government |
( |
) | ||||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||||||
Utilities |
||||||||||||||||||||||||
Energy |
( |
) | ||||||||||||||||||||||
Finance and insurance |
( |
) | ||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ||||||||||||||||||||||
Technology and communications |
( |
) | ||||||||||||||||||||||
Industrial |
||||||||||||||||||||||||
Capital goods |
( |
) | ||||||||||||||||||||||
Consumer—cyclical |
( |
) | ||||||||||||||||||||||
Transportation |
( |
) | ||||||||||||||||||||||
Other |
||||||||||||||||||||||||
Total U.S. corporate |
( |
) | ||||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||||||
Utilities |
||||||||||||||||||||||||
Energy |
||||||||||||||||||||||||
Finance and insurance |
||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ||||||||||||||||||||||
Technology and communications |
||||||||||||||||||||||||
Industrial |
||||||||||||||||||||||||
Capital goods |
||||||||||||||||||||||||
Consumer—cyclical |
||||||||||||||||||||||||
Transportation |
( |
) | ||||||||||||||||||||||
Other |
( |
) | ||||||||||||||||||||||
Total non-U.S. corporate |
( |
) | ||||||||||||||||||||||
Residential mortgage-backed |
( |
) | ||||||||||||||||||||||
Commercial mortgage-backed |
( |
) | ||||||||||||||||||||||
Other asset-backed |
( |
) | ||||||||||||||||||||||
Total available-for-sale fixed maturity securities |
$ | $ | $ | $ | ( |
) | $ | $ |
||||||||||||||||
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
(Dollar amounts in millions) |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
|||||||||||||||||||||||||||
Description of Securities |
||||||||||||||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||
State and political subdivisions |
$ | $ | ( |
) | $ | $ | $ | $ | ( |
) |
||||||||||||||||||||||||||
Non-U.S. government |
( |
) | ( |
) |
||||||||||||||||||||||||||||||||
U.S. corporate |
( |
) | ( |
) |
( |
) |
||||||||||||||||||||||||||||||
Non-U.S. corporate |
( |
) | ( |
) |
( |
) |
||||||||||||||||||||||||||||||
Residential mortgage-backed |
( |
) | ( |
) |
( |
) |
||||||||||||||||||||||||||||||
Commercial mortgage-backed |
( |
) | ( |
) |
( |
) |
||||||||||||||||||||||||||||||
Other asset-backed |
( |
) | ( |
) |
( |
) |
||||||||||||||||||||||||||||||
Total for fixed maturity securities inan unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
% Below cost: |
||||||||||||||||||||||||||||||||||||
<20% Below cost |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) |
||||||||||||||||||||||||
20%-50% Below cost |
( |
) | ( |
) |
( |
) |
||||||||||||||||||||||||||||||
>50% Below cost |
( |
) | ( |
) |
( |
) |
||||||||||||||||||||||||||||||
Total for fixed maturity securities inan unrealized loss position |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Investment grade |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) |
||||||||||||||||||||||||
Below investment grade |
( |
) | ( |
) |
( |
) |
||||||||||||||||||||||||||||||
Total for fixed maturity securities inan unrealized loss position |
$ |
$ | ( |
) | $ | $ | ( |
) | $ |
$ | ( |
) | ||||||||||||||||||||||||
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
(Dollar amounts in millions) |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
|||||||||||||||||||||||||||
Description of Securities |
||||||||||||||||||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||||||||||||||||||
Utilities |
$ | $ | ( |
) | $ | $ | $ | $ | ( |
) | ||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Consumer—non- |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Technology andcommunications |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Subtotal, U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Consumer—non- |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Technology andcommunications |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Subtotal, non-U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Total for corporate securities in anunrealized loss position |
$ |
$ | ( |
) | $ | $ | ( |
) | $ |
$ | ( |
) | ||||||||||||||||||||||||
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
(Dollar amounts in millions) |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
|||||||||||||||||||||||||||
Description of Securities |
||||||||||||||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||
State and political subdivisions |
$ | $ | ( |
) | $ | $ | $ | $ | ( |
) |
||||||||||||||||||||||||||
Non-U.S. government |
( |
) | ( |
) |
||||||||||||||||||||||||||||||||
U.S. corporate |
( |
) | ( |
) |
( |
) |
||||||||||||||||||||||||||||||
Non-U.S. corporate |
( |
) | ( |
) |
( |
) |
||||||||||||||||||||||||||||||
Residential mortgage-backed |
( |
) | ( |
) |
||||||||||||||||||||||||||||||||
Commercial mortgage-backed |
( |
) | ( |
) |
( |
) |
||||||||||||||||||||||||||||||
Other asset-backed |
( |
) | ( |
) |
( |
) |
||||||||||||||||||||||||||||||
Total for fixed maturity securities in |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
% Below cost: |
||||||||||||||||||||||||||||||||||||
<20% Below cost |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
20%-50% Below cost |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||
Total for fixed maturity securities in |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Investment grade |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Below investment grade |
( |
) | ( |
) |
( |
) |
||||||||||||||||||||||||||||||
Total for fixed maturity securities in |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
(Dollar amounts in millions) |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
|||||||||||||||||||||||||||
Description of Securities |
||||||||||||||||||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||||||||||||||||||
Energy |
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Technology and |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Subtotal, U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||
Consumer—non-cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Subtotal, non-U.S. corporate |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Total for corporate securities in anunrealized loss position |
$ |
$ | ( |
) | $ |
$ | ( |
) | $ | $ | ( |
) | ||||||||||||||||||||||||
(Amounts in millions) |
Amortized cost or cost |
Fair value |
||||||
Due one year or less |
$ |
$ |
||||||
Due after one year through five years |
||||||||
Due after five years through ten years |
||||||||
Due after ten years |
||||||||
Subtotal |
||||||||
Residential mortgage-backed |
||||||||
Commercial mortgage-backed |
||||||||
Other asset-backed |
||||||||
Total |
$ |
$ |
||||||
March 31, 2020 |
December 31, 2019 |
|||||||||||||||
(Amounts in millions) |
Carrying value |
% of total |
Carrying value |
% of total |
||||||||||||
Property type: |
||||||||||||||||
Retail |
$ | % | $ | % | ||||||||||||
Industrial |
||||||||||||||||
Office |
||||||||||||||||
Apartments |
||||||||||||||||
Mixed use |
||||||||||||||||
Other |
||||||||||||||||
Subtotal |
% | % | ||||||||||||||
Unamortized balance of loan origination fees |
( |
) | ||||||||||||||
Allowance for credit losses |
( |
) | ( |
) | ||||||||||||
Total |
$ | $ | ||||||||||||||
March 31, 2020 |
December 31, 2019 |
|||||||||||||||
(Amounts in millions) |
Carrying value |
% of total |
Carrying value |
% of total |
||||||||||||
Geographic region: |
||||||||||||||||
South Atlantic |
$ | |
|
% | $ | |
|
% | ||||||||
Pacific |
|
|
|
|
||||||||||||
Middle Atlantic |
|
|
|
|
||||||||||||
Mountain |
|
|
|
|
||||||||||||
West North Central |
|
|
|
|
||||||||||||
East North Central |
|
|
|
|
||||||||||||
West South Central |
|
|
|
|
||||||||||||
New England |
|
|
|
|
||||||||||||
East South Central |
|
|
|
|
||||||||||||
Subtotal |
|
|
% | 6,980 |
|
% | ||||||||||
Unamortized balance of loan origination fees |
|
( |
) | |||||||||||||
Allowance for credit losses |
( |
) | ( |
) | ||||||||||||
Total |
$ | |
$ | |
||||||||||||
March 31, 2020 |
||||||||||||||||||||||||
(Amounts in millions) |
31 - 60 dayspast due |
61 - 90 days past due |
Greater than 90 days past due |
Total past due |
Current |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||||
Industrial |
|
|
|
|
|
|
||||||||||||||||||
Office |
|
|
|
|
|
|
||||||||||||||||||
Apartments |
|
|
|
|
|
|
||||||||||||||||||
Mixed use |
|
|
|
|
|
|
||||||||||||||||||
Other |
|
|
|
|
|
|
||||||||||||||||||
Total amortized cost |
$ | |
$ | |
$ | |
$ | |
$ |
|
$ |
|
||||||||||||
% of total commercial mortgage loans |
|
% | |
% | |
% | |
% | |
% | |
% | ||||||||||||
December 31, 2019 |
||||||||||||||||||||||||
(Amounts in millions) |
31 - 60 days past due |
61 - 90 days past due |
Greater than 90 days past due |
Total past due |
Current |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||||
Industrial |
|
|
|
|
|
|
||||||||||||||||||
Office |
|
|
|
|
|
|
||||||||||||||||||
Apartments |
|
|
|
|
|
|
||||||||||||||||||
Mixed use |
|
|
|
|
|
|
||||||||||||||||||
Other |
|
|
|
|
|
|
||||||||||||||||||
Total recorded investment |
$ | |
$ | |
$ | |
$ |
|
$ | |
$ | 6,980 |
||||||||||||
% of total commercial mortgage loans |
|
% | |
% | |
% | |
% | |
% | |
% | ||||||||||||
Three months ended March 31, |
||||||||
(Amounts in millions) |
2020 |
2019 |
||||||
Allowance for credit losses: |
||||||||
Beginning balance |
$ | |
$ | |
||||
Cumulative effect of change in accounting |
|
|
||||||
Provision |
|
|
||||||
Write-offs |
|
|
||||||
Recoveries |
|
|
||||||
Ending balance |
$ | |
$ | |
||||
March 31, 2020 |
||||||||||||||||||||||||
(Amounts in millions) |
0% - 50% |
51% - 60% |
61% - 75% |
76% - 100% |
Greater than 100% |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||||
Industrial |
|
|
|
|
|
|
||||||||||||||||||
Office |
|
|
|
|
|
|
||||||||||||||||||
Apartments |
|
|
|
|
|
|
||||||||||||||||||
Mixed use |
|
|
|
|
|
|
||||||||||||||||||
Other |
|
|
|
|
|
|
||||||||||||||||||
Total amortized cost |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||||
% of total |
|
% | |
% | |
% | |
% | |
% | |
% | ||||||||||||
Weighted-average debt service coverage ratio |
|
|
|
|
|
|
||||||||||||||||||
December 31, 2019 |
||||||||||||||||||||||||
(Amounts in millions) |
0% - 50% |
51% - 60% |
61% - 75% |
76% - 100% |
Greater than 100% |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||||
Industrial |
|
|
|
|
|
|
||||||||||||||||||
Office |
|
|
|
|
|
|
||||||||||||||||||
Apartments |
|
|
|
|
|
|
||||||||||||||||||
Mixed use |
|
|
|
|
|
|
||||||||||||||||||
Other |
|
|
|
|
|
|
||||||||||||||||||
Total recorded investment |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | 6,980 |
||||||||||||
% of total |
|
% | |
% | |
% | |
% | |
% | |
% | ||||||||||||
Weighted-average debt service coverage ratio |
|
|
|
|
|
|
||||||||||||||||||
March 31, 2020 |
||||||||||||||||||||||||
(Amounts in millions) |
Less than 1.00 |
1.00 - 1.25 |
1.26 - 1.50 |
1.51 - 2.00 |
Greater than 2.00 |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||||
Industrial |
|
|
|
|
|
|
||||||||||||||||||
Office |
|
|
|
|
|
|
||||||||||||||||||
Apartments |
|
|
|
|
|
|
||||||||||||||||||
Mixed use |
|
|
|
|
|
|
||||||||||||||||||
Other |
|
|
|
|
|
|
||||||||||||||||||
Total amortized cost |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||||
% of total |
|
% | |
% | |
% | |
% | |
% | |
% | ||||||||||||
Weighted-average debt-to-value |
|
% | |
% | |
% | |
% | |
% | |
% | ||||||||||||
December 31, 2019 |
||||||||||||||||||||||||
(Amounts in millions) |
Less than 1.00 |
1.00 - 1.25 |
1.26 - 1.50 |
1.51 - 2.00 |
Greater than 2.00 |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | |
$ | |
$ | |
$ | |
$ | |
$ |
|
||||||||||||
Industrial |
|
|
|
|
|
|
||||||||||||||||||
Office |
|
|
|
|
|
|
||||||||||||||||||
Apartments |
|
|
|
|
|
|
||||||||||||||||||
Mixed use |
|
|
|
|
|
|
||||||||||||||||||
Other |
|
|
|
|
|
|
||||||||||||||||||
Total recorded investment |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||||
% of total |
|
% | |
% | |
% | |
% | |
% | |
% | ||||||||||||
Weighted-average debt-to-value |
|
% | |
% | |
% | |
% | |
% | |
% | ||||||||||||
(Amounts in millions) |
2020 |
2019 |
2018 |
2017 |
2016 |
2015 and prior |
Total |
|||||||||||||||||||||
Debt-to-value: |
||||||||||||||||||||||||||||
0% - 50% |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
51% - 60% |
||||||||||||||||||||||||||||
61% - 75% |
||||||||||||||||||||||||||||
76% - 100% |
||||||||||||||||||||||||||||
Greater than 100% |
||||||||||||||||||||||||||||
Total amortized cost |
$ |
$ |
$ |
$ |
$ |
$ | $ |
|||||||||||||||||||||
Debt service coverage ratio: |
||||||||||||||||||||||||||||
Less than 1.00 |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
1.00 - 1.25 |
||||||||||||||||||||||||||||
1.26 - 1.50 |
||||||||||||||||||||||||||||
1.51 - 2.00 |
||||||||||||||||||||||||||||
Greater than 2.00 |
||||||||||||||||||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
Write-offs, gross |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
Recoveries |
||||||||||||||||||||||||||||
Write-offs, net |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
Derivative assets |
Derivative liabilities |
|||||||||||||||||||
Balance classification |
Fair value |
Balance classification |
Fair value |
|||||||||||||||||
(Amounts in millions) |
March 31, 2020 |
December 31, 2019 |
March 31, 2020 |
December 31, 2019 |
||||||||||||||||
Derivatives designated as |
||||||||||||||||||||
Cash flow hedges: |
||||||||||||||||||||
Interest rate swaps |
Other invested assets |
$ | $ | Other liabilities |
$ | $ | ||||||||||||||
Foreign currency swaps |
Other invested assets |
Other liabilities |
||||||||||||||||||
Total cash flow |
||||||||||||||||||||
Total derivatives |
||||||||||||||||||||
Derivatives not designated as |
||||||||||||||||||||
Equity index options |
Other invested assets |
Other liabilities |
||||||||||||||||||
Financial futures |
Other invested assets |
Other liabilities |
||||||||||||||||||
Other foreign currency |
Other invested assets |
Other liabilities |
||||||||||||||||||
GMWB embeddedderivatives |
Reinsurance (1) |
Policyholder account balances (2) |
||||||||||||||||||
Fixed index annuity embedded |
Other assets |
Policyholder (3) |
||||||||||||||||||
Indexed universal lifeembedded |
Reinsurance |
Policyholder account balances (4) |
||||||||||||||||||
Total derivatives not |
||||||||||||||||||||
Total derivatives |
$ | $ | $ | $ | ||||||||||||||||
(1) |
Represents embedded derivatives associated with the reinsured portion of our guaranteed minimum withdrawal benefits (“GMWB”) liabilities. |
(2) |
Represents the embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
(3) |
Represents the embedded derivatives associated with our fixed index annuity liabilities. |
(4) |
Represents the embedded derivatives associated with our indexed universal life liabilities. |
(Notional in millions) |
Measurement |
December 31, 2019 |
Additions |
Maturities/ terminations |
March 31, 2020 |
|||||||||||||||
Derivatives designated as hedges |
||||||||||||||||||||
Cash flow hedges: |
||||||||||||||||||||
Interest rate swaps |
Notional |
$ | $ | $ | ( |
) | $ | |||||||||||||
Foreign currency swaps |
Notional |
|||||||||||||||||||
Total cash flow hedges |
( |
) | ||||||||||||||||||
Total derivatives designated as hedges |
( |
) | ||||||||||||||||||
Derivatives not designated as hedges |
||||||||||||||||||||
Interest rate swaps |
Notional |
|||||||||||||||||||
Equity index options |
Notional |
( |
) | |||||||||||||||||
Financial futures |
Notional |
( |
) | |||||||||||||||||
Other foreign currency contracts |
Notional |
( |
) | |||||||||||||||||
Total derivatives not designated as hedges |
( |
) | ||||||||||||||||||
Total derivatives |
$ | $ | $ | ( |
) | $ | ||||||||||||||
(Number of policies) |
Measurement |
December 31, 2019 |
Additions |
Maturities/ terminations |
March 31, 2020 |
|||||||||||||||
Derivatives not designated as hedges |
||||||||||||||||||||
GMWB embedded derivatives |
Policies |
( |
) | |||||||||||||||||
Fixed index annuity embedded derivatives |
Policies |
( |
) | |||||||||||||||||
Indexed universal life embedded derivatives |
Policies |
( |
) |
(Amounts in millions) |
Gain (loss) recognized in OCI |
Gain (loss) reclassified into net income (loss) from OCI |
Classification of gain (loss) reclassified into net income (loss) |
Gain (loss) recognized in net income (loss) |
Classification of gain (loss) recognized in net income (loss) |
|||||||||||||||
Interest rate swaps hedging assets |
$ | $ | Net investment income |
$ | Net investment gains (losses) |
|||||||||||||||
Interest rate swaps hedging assets |
Net investment gains (losses) |
Net investment gains (losses) |
||||||||||||||||||
Interest rate swaps hedging liabilities |
( |
) | Interest expense |
Net investment gains (losses) |
||||||||||||||||
Foreign currency swaps |
Net investment income |
Net investment gains (losses) |
||||||||||||||||||
Total |
$ | $ | $ | |||||||||||||||||
(Amounts in millions) |
Gain (loss) recognized in OCI |
Gain (loss) reclassified into net income (loss) from OCI |
Classification of gain (loss) reclassified into net income (loss) |
Gain (loss) recognized in net income (loss) |
Classification of gain (loss) recognized in net income (loss) |
|||||||||||||||
Interest rate swaps hedging assets |
$ | $ | Net investment income |
$ | Net investment gains (losses) |
|||||||||||||||
Interest rate swaps hedging assets |
Net investment gains (losses) |
Net investment gains (losses) |
||||||||||||||||||
Interest rate swaps hedging liabilities |
( |
) | Interest expense |
Net investment gains (losses) |
||||||||||||||||
Foreign currency swaps |
( |
) | Net investment income |
Net investment gains (losses) |
||||||||||||||||
Forward currency swaps |
Net investment gains (losses) |
Net investment gains (losses) |
||||||||||||||||||
Total |
$ | $ | $ | |||||||||||||||||
Three months ended March 31, |
||||||||
(Amounts in millions) |
2020 |
2019 |
||||||
Derivatives qualifying as effective accounting hedges as of January 1 |
$ | |
$ | |
||||
Current period increases (decreases) in fair value, net of deferred taxes of $( |
|
|
||||||
Reclassification to net (income) loss, net of deferred taxes of $ |
( |
) | ( |
) | ||||
Derivatives qualifying as effective accounting hedges as of March 31 |
$ | |
$ | |
||||
|
Three months ended March 31, |
Classification of gain (loss) recognized in net income (loss) |
||||||||||
(Amounts in millions) |
2020 |
2019 |
||||||||||
Interest rate swaps |
$ | ( |
) | $ | ( |
) | Net investment gains (losses) |
|||||
Equity index options |
( |
) | |
Net investment gains (losses) |
||||||||
Financial futures |
|
( |
) | Net investment gains (losses) |
||||||||
Other foreign currency contracts |
( |
) | |
Net investment gains (losses) |
||||||||
GMWB embedded derivatives |
( |
) | |
Net investment gains (losses) |
||||||||
Fixed index annuity embedded derivatives |
|
( |
) | Net investment gains (losses) |
||||||||
Indexed universal life embedded derivatives |
|
|
Net investment gains (losses) |
|||||||||
Total derivatives not designated as hedges |
$ |
( |
) | $ |
( |
) | ||||||
March 31, 2020 |
December 31, 2019 |
|||||||||||||||||||||||
(Amounts in millions) |
Derivative assets (1) |
Derivative liabilities (2) |
Net derivatives |
Derivative assets (1) |
Derivative liabilities (2) |
Net derivatives |
||||||||||||||||||
Amounts presented in the balance sheet: |
||||||||||||||||||||||||
Gross amounts recognized |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||||
Gross amounts offset in the balance sheet |
|
|
|
|
|
|
||||||||||||||||||
Net amounts presented in the balance sheet |
|
|
|
|
|
|
||||||||||||||||||
Gross amounts not offset in the balance sheet: |
||||||||||||||||||||||||
Financial instruments (3) |
|
|
|
( |
) |
( |
) |
|
||||||||||||||||
Collateral received |
( |
) |
|
( |
) | ( |
) |
|
( |
) | ||||||||||||||
Collateral pledged |
|
( |
) |
|
|
( |
) |
|
||||||||||||||||
Over collateralization |
|
|
( |
) | |
|
( |
) | ||||||||||||||||
Net amount |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||||
(1) |
Included $ |
(2) |
Does not include amounts related to embedded derivatives as of March 31, 2020 and December 31, 2019. |
(3) |
Amounts represent derivative assets and/or liabilities that are presented gross within the balance sheet but are held with the same counterparty where we have a master netting arrangement. This adjustment results in presenting the net asset and net liability position for each counterparty. |
• | Third-party pricing services: |
and type of inputs used may change frequently as certain inputs may be more direct drivers of valuation at the time of pricing. Examples of significant inputs incorporated by third-party pricing services may include sector and issuer spreads, seasoning, capital structure, security optionality, collateral data, prepayment assumptions, default assumptions, delinquencies, debt covenants, benchmark yields, trade data, dealer quotes, credit ratings, maturity and weighted-average life. We conduct regular meetings with our third-party pricing services for the purpose of understanding the methodologies, techniques and inputs used by the third-party pricing providers. |
(Amounts in millions) |
Fair value |
|
|
|||||||||
U.S. government, agencies and government-sponsored enterprises |
$ |
|
|
|
||||||||
State and political subdivisions |
$ |
|
|
|
||||||||
Non-U.S. gov ernment |
$ |
|
|
|
||||||||
U.S. corporate |
$ |
|
based models |
|
||||||||
Non-U.S. corporate |
$ |
|
|
|
||||||||
Residential m o rtgage-backed |
$ |
|
|
|
||||||||
Commercial mortgage-backed |
$ |
|
|
|
||||||||
Other asset-backed |
$ |
|
|
|
• |
Internal models: non-U.S. government, U.S. corporate and non-U.S. corporate securities are valued using internal models. The fair value of these fixed maturity securities was $ |
• | Broker quotes: non-U.S. government, U.S. corporate, non-U.S. corporate, residential mortgage-backed and other asset-backed securities are valued using broker quotes. Broker quotes are obtained from third-party providers that have current market knowledge to provide a reasonable price for securities not routinely priced by third-party pricing services. Brokers utilized for valuation of assets are reviewed annually. The fair value of our Level 3 fixed maturity securities priced by broker quotes was $ |
• | Internal models: non-U.S. corporate, residential mortgage-backed and other asset-backed securities are valued using internal models. The primary inputs to the valuation of the bond population include quoted prices for identical assets, or similar assets in markets that are not active, contractual cash flows, duration, call provisions, issuer rating, benchmark yields and credit spreads. Certain private fixed maturity securities are valued using an internal model using market observable inputs such as the interest rate yield curve, as well as published credit spreads for similar securities, which includes significant unobservable inputs. Additionally, we may apply certain price caps and liquidity premiums in the valuation of private fixed maturity securities. Price caps are established using inputs from market participants. For structured securities, the primary inputs to the valuation include quoted prices for identical assets, or similar assets in markets that are not active, contractual cash flows, weighted-average coupon, weighted-average maturity, issuer rating, structure of the security, expected prepayment speeds and volumes, collateral type, current and forecasted loss severity, average delinquency rates, vintage of the loans, |
geographic region, debt service coverage ratios, payment priority with the tranche, benchmark yields and credit spreads. The fair value of our Level 3 fixed maturity securities priced using internal models was $ |
March 31, 2020 |
||||||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
NAV (1) |
|||||||||||||||
Assets |
||||||||||||||||||||
Investments: |
||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||
State and political subdivisions |
|
|
|
|
|
|||||||||||||||
Non-U.S. government |
|
|
|
|
|
|||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
|
|
|
|
|
|||||||||||||||
Energy |
|
|
|
|
|
|||||||||||||||
Finance and insurance |
|
|
|
|
|
|||||||||||||||
Consumer—non-cyclical |
|
|
|
|
|
|||||||||||||||
Technology and communications |
|
|
|
|
|
|||||||||||||||
Industrial |
|
|
|
|
|
|||||||||||||||
Capital goods |
|
|
|
|
|
|||||||||||||||
Consumer—cyclical |
|
|
|
|
|
|||||||||||||||
Transportation |
|
|
|
|
|
|||||||||||||||
Other |
|
|
|
|
|
|||||||||||||||
Total U.S. corporate |
|
|
|
|
|
|||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
|
|
|
|
|
|||||||||||||||
Energy |
|
|
|
|
|
|||||||||||||||
Finance and insurance |
|
|
|
|
|
|||||||||||||||
Consumer—non-cyclical |
|
|
|
|
|
|||||||||||||||
Technology and communications |
|
|
|
|
|
|||||||||||||||
Industrial |
|
|
|
|
|
|||||||||||||||
Capital goods |
|
|
|
|
|
|||||||||||||||
Consumer—cyclical |
|
|
|
|
|
|||||||||||||||
Transportation |
|
|
|
|
|
|||||||||||||||
Other |
|
|
|
|
|
|||||||||||||||
Total non-U.S. corporate |
|
|
|
|
|
|||||||||||||||
Residential mortgage-backed |
|
|
|
|
|
|||||||||||||||
Commercial mortgage-backed |
|
|
|
|
|
|||||||||||||||
Other asset-backed |
|
|
|
|
|
|||||||||||||||
Total fixed maturity securities |
|
|
|
|
|
|||||||||||||||
Equity securities |
|
|
|
|
|
|||||||||||||||
Other invested assets: |
||||||||||||||||||||
Derivative assets: |
||||||||||||||||||||
Interest rate swaps |
|
|
|
|
|
|||||||||||||||
Foreign currency swaps |
|
|
|
|
|
|||||||||||||||
Equity index options |
|
|
|
|
|
|||||||||||||||
Other foreign currency contracts |
|
|
|
|
|
|||||||||||||||
Total derivative assets |
|
|
|
|
|
|||||||||||||||
Securities lending collateral |
|
|
|
|
|
|||||||||||||||
Short-term investments |
|
|
|
|
|
|||||||||||||||
Limited partnerships |
|
|
|
|
|
|||||||||||||||
Total other invested assets |
|
|
|
|
|
|||||||||||||||
Reinsurance recoverable (2) |
|
|
|
|
|
|||||||||||||||
Separate account assets |
|
|
|
|
|
|||||||||||||||
Total assets |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||
(1) |
Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. |
(2) |
Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. |
December 31, 2019 |
||||||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
NAV (1) |
|||||||||||||||
Assets |
||||||||||||||||||||
Investments: |
||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ | |
$ | |
$ | |
$ |
|
$ | |
||||||||||
State and political subdivisions |
|
|
|
|
|
|||||||||||||||
Non-U.S. government |
|
|
|
|
|
|||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
|
|
|
|
|
|||||||||||||||
Energy |
|
|
|
|
|
|||||||||||||||
Finance and insurance |
|
|
|
|
|
|||||||||||||||
Consumer—non-cyclical |
|
|
|
|
|
|||||||||||||||
Technology and communications |
|
|
|
|
|
|||||||||||||||
Industrial |
|
|
|
|
|
|||||||||||||||
Capital goods |
|
|
|
|
|
|||||||||||||||
Consumer—cyclical |
|
|
|
|
|
|||||||||||||||
Transportation |
|
|
|
|
|
|||||||||||||||
Other |
|
|
|
|
|
|||||||||||||||
Total U.S. corporate |
|
|
|
|
|
|||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
|
|
|
|
|
|||||||||||||||
Energy |
|
|
|
|
|
|||||||||||||||
Finance and insurance |
|
|
|
|
|
|||||||||||||||
Consumer—non-cyclical |
|
|
|
|
|
|||||||||||||||
Technology and communications |
|
|
|
|
|
|||||||||||||||
Industrial |
|
|
|
|
|
|||||||||||||||
Capital goods |
|
|
|
|
|
|||||||||||||||
Consumer—cyclical |
|
|
|
|
|
|||||||||||||||
Transportation |
|
|
|
|
|
|||||||||||||||
Other |
|
|
|
|
|
|||||||||||||||
Total non-U.S. corporate |
|
|
|
|
|
|||||||||||||||
Residential mortgage-backed |
|
|
|
|
|
|||||||||||||||
Commercial mortgage-backed |
|
|
|
|
|
|||||||||||||||
Other asset-backed |
|
|
|
|
|
|||||||||||||||
Total fixed maturity securities |
|
|
|
|
|
|||||||||||||||
Equity securities |
|
|
|
|
|
|||||||||||||||
Other invested assets: |
||||||||||||||||||||
Derivative assets: |
||||||||||||||||||||
Interest rate swaps |
|
|
|
|
|
|||||||||||||||
Foreign currency swaps |
|
|
|
|
|
|||||||||||||||
Equity index options |
|
|
|
|
|
|||||||||||||||
Other foreign currency contracts |
|
|
|
|
|
|||||||||||||||
Total derivative assets |
|
|
|
|
|
|||||||||||||||
Securities lending collateral |
|
|
|
|
|
|||||||||||||||
Short-term investments |
|
|
|
|
|
|||||||||||||||
Limited partnerships |
|
|
|
|
|
|||||||||||||||
Total other invested assets |
|
|
|
|
|
|||||||||||||||
Reinsurance recoverable (2) |
|
|
|
|
|
|||||||||||||||
Separate account assets |
|
|
|
|
|
|||||||||||||||
Total assets |
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||
(1) |
Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. |
(2) |
Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. |
Beginning balance as of January 1, 2020 |
Total realized and unrealized gains (losses) |
Ending balance as of March 31, 2020 |
Total gains (losses) attributable to assets still held |
|||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) |
Included in net income (loss) |
Included in OCI |
Purchases |
Sales |
Issuances |
Settlements |
Transfer into Level 3 (1) |
Transfer out of Level (1) |
Included in net income (loss) |
Included in OCI |
||||||||||||||||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||||||||||||||
State and political subdivisions |
$ |
$ |
$ |
( |
) | $ |
$ |
$ |
$ |
( |
) | $ |
$ |
$ |
$ |
$ |
( |
) | ||||||||||||||||||||||||||||||
Non-U.S. government |
||||||||||||||||||||||||||||||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Consumer— non-cyclical |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Technology and communications |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Total U.S. corporate |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||||||
Utilities |
( |
) | ( |
) |
( |
) | ||||||||||||||||||||||||||||||||||||||||||
Energy |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Finance and insurance |
( |
) | ( |
) |
( |
) | ||||||||||||||||||||||||||||||||||||||||||
Consumer— non-cyclical |
( |
) | ( |
) |
( |
) | ||||||||||||||||||||||||||||||||||||||||||
Technology and |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Industrial |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Capital goods |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Consumer—cyclical |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Transportation |
( |
) | ( |
) |
( |
) | ||||||||||||||||||||||||||||||||||||||||||
Other |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Total non-U.S. corporate |
( |
) | ( |
) | ( |
) |
( |
) | ||||||||||||||||||||||||||||||||||||||||
Residential mortgage-backed |
( |
) | ( |
) |
( |
) | ||||||||||||||||||||||||||||||||||||||||||
Commercial mortgage-backed |
( |
) |
||||||||||||||||||||||||||||||||||||||||||||||
Other asset-backed |
( |
) | ( |
) | ( |
) |
( |
) | ||||||||||||||||||||||||||||||||||||||||
Total fixed maturity securities |
( |
) | ( |
) | ( |
) | ( |
) |
( |
) | ||||||||||||||||||||||||||||||||||||||
Equity securities |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Other invested assets: |
||||||||||||||||||||||||||||||||||||||||||||||||
Derivative assets: |
||||||||||||||||||||||||||||||||||||||||||||||||
Equity index options |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Total derivative assets |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Total other invested assets |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Reinsurance recoverable (2) |
||||||||||||||||||||||||||||||||||||||||||||||||
Total Level 3 assets |
$ | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | $ | $ | $ | ( |
) | ||||||||||||||||||||||||||
(1) |
The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. |
(2) |
Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. |
|
Beginning balance as of January 1, 2019 |
Total realized and unrealized gains (losses) |
|
|
|
|
|
|
Ending balance as of March 31, 2019 |
Total gains (losses) included in net income (loss) attributable to assets still held |
||||||||||||||||||||||||||||||||||
(Amounts in millions) |
Included in net income (loss) |
Included in OCI |
Purchases |
Sales |
Issuances |
Settlements |
Transfer into Level 3 (1) |
Transfer out of Level 3 (1) |
||||||||||||||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||||||||||
State and political subdivisions |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ |
$ | |
$ | |
|||||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||
Utilities |
|
|
|
|
( |
) | |
( |
) | |
|
|
|
|||||||||||||||||||||||||||||||
Energy |
|
|
|
|
|
|
( |
) | |
|
|
|
||||||||||||||||||||||||||||||||
Finance and insurance |
|
|
|
|
|
|
( |
) | |
|
|
|
||||||||||||||||||||||||||||||||
Consumer— non-cyclical |
|
|
|
|
|
|
( |
) | |
|
|
|
||||||||||||||||||||||||||||||||
Technology and |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
Industrial |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
Capital goods |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
Consumer—cyclical |
|
|
|
|
( |
) | |
( |
) | |
( |
) |
|
|
||||||||||||||||||||||||||||||
Transportation |
|
|
|
|
|
|
( |
) | |
|
|
|
||||||||||||||||||||||||||||||||
Other |
|
|
|
|
|
|
( |
) | |
|
|
|
||||||||||||||||||||||||||||||||
Total U.S. corporate |
|
|
|
|
( |
) | |
( |
) | |
( |
) |
|
|
||||||||||||||||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||||||||||
Utilities |
|
|
|
|
|
|
|
|
( |
) | |
|
||||||||||||||||||||||||||||||||
Energy |
|
|
|
|
|
|
( |
) | |
|
|
|
||||||||||||||||||||||||||||||||
Finance and insurance |
|
|
|
|
|
|
|
|
( |
) |
|
|
||||||||||||||||||||||||||||||||
Consumer— non-cyclical |
|
|
|
|
|
|
( |
) | |
|
|
|
||||||||||||||||||||||||||||||||
Technology and |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
Industrial |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
Capital goods |
|
|
|
|
|
|
( |
) | |
|
|
|
||||||||||||||||||||||||||||||||
Consumer—cyclical |
|
|
|
|
|
|
( |
) | |
|
|
|
||||||||||||||||||||||||||||||||
Transportation |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
Other |
|
|
|
|
|
|
( |
) | |
|
|
|
||||||||||||||||||||||||||||||||
Total non-U.S. corporate |
|
|
|
|
|
|
( |
) | |
( |
) | |
|
|||||||||||||||||||||||||||||||
Residential mortgage- backed |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
Commercial mortgage- backed |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
Other asset-backed |
|
|
|
|
|
|
( |
) | |
|
|
|
||||||||||||||||||||||||||||||||
Total fixed maturity securities |
|
|
|
|
( |
) | |
( |
) | |
( |
) | |
|
||||||||||||||||||||||||||||||
Equity securities |
|
|
|
|
( |
) | |
|
|
|
|
|
||||||||||||||||||||||||||||||||
Other invested assets: |
||||||||||||||||||||||||||||||||||||||||||||
Derivative assets: |
||||||||||||||||||||||||||||||||||||||||||||
Equity index options |
|
|
|
|
|
|
( |
) | |
|
|
|
||||||||||||||||||||||||||||||||
Total derivative assets |
|
|
|
|
|
|
( |
) | |
|
|
|
||||||||||||||||||||||||||||||||
Total other invested assets |
|
|
|
|
|
|
( |
) | |
|
|
|
||||||||||||||||||||||||||||||||
Reinsurance recoverable (2) |
|
( |
) | |
|
|
|
|
|
|
|
( |
) | |||||||||||||||||||||||||||||||
Total Level 3 assets |
$ | |
$ | |
$ | |
$ | |
$ | ( |
) | $ | |
$ | ( |
) | $ | |
$ | ( |
) | $ | |
$ | |
|||||||||||||||||||
(1) |
The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. |
(2) |
Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. |
(Amounts in millions) |
2020 |
2019 |
||||||
Total realized and unrealized gains (losses) included in net income (loss): |
||||||||
Net investment income |
$ |
$ | |
|||||
Net investment gains (losses) |
|
|
||||||
Total |
$ |
$ | |
|||||
Net gains (losses) included in net income (loss) attributable to assets still held: |
||||||||
Net investment income |
$ |
$ | |
|||||
Net investment gains (losses) |
|
|
||||||
Total |
$ |
$ | |
|||||
(Amounts in millions) |
Valuation technique |
Fair value |
Unobservable input |
Range |
Weighted-average (1) |
|||||||||||||
Fixed maturity securities: |
||||||||||||||||||
U.S. corporate: |
||||||||||||||||||
Utilities |
|
$ | |
Credit spreads |
- |
|
||||||||||||
Energy |
|
|
Credit spreads |
|
|
|||||||||||||
Finance and insurance |
|
|
Credit spreads |
|
|
|||||||||||||
Consumer— |
|
|
Credit spreads |
|
|
|||||||||||||
Technology and |
|
|
Credit spreads |
|
|
|||||||||||||
Industrial |
|
|
Credit spreads |
|
|
|||||||||||||
Capital goods |
|
|
Credit spreads |
|
|
|||||||||||||
Consumer—cyclical |
|
|
Credit spreads |
|
|
|||||||||||||
Transportation |
|
|
Credit spreads |
|
|
|||||||||||||
Other |
|
|
Credit spreads |
|
|
|||||||||||||
Total U.S. corporate |
|
$ | |
Credit spreads |
|
|
||||||||||||
Non-U.S. corporate: |
||||||||||||||||||
Utilities |
|
$ | |
Credit spreads |
|
|
||||||||||||
Energy |
|
|
Credit spreads |
|
|
|||||||||||||
Finance and insurance |
|
|
Credit spreads |
|
|
|||||||||||||
Consumer— |
|
|
Credit spreads |
|
|
|||||||||||||
Technology and |
|
|
Credit spreads |
|
|
|||||||||||||
Industrial |
|
|
Credit spreads |
|
|
|||||||||||||
Capital goods |
|
|
Credit spreads |
|
|
|||||||||||||
Consumer— |
|
|
Credit spreads |
|
|
|||||||||||||
Transportation |
|
|
Credit spreads |
|
|
|||||||||||||
Other |
|
|
Credit spreads |
|
|
|||||||||||||
Total non-U.S. corporate |
|
$ | |
Credit spreads |
|
|
||||||||||||
Derivative assets: |
||||||||||||||||||
Equity index options |
|
$ | |
Equity index volatility |
|
|
(1) |
Unobservable inputs weighted by the relative fair value of the associated instrument for fixed maturity securities and by notional for derivative assets. |
March 31, 2020 |
||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
Liabilities |
||||||||||||||||
Policyholder account balances: |
||||||||||||||||
GMWB embedded derivatives (1) |
$ | $ | $ | $ | ||||||||||||
Fixed index annuity embedded derivatives |
||||||||||||||||
Indexed universal life embedded derivatives |
||||||||||||||||
Total policyholder account balances |
||||||||||||||||
Derivative liabilities: |
||||||||||||||||
Other foreign currency contracts |
||||||||||||||||
Total derivative liabilities |
||||||||||||||||
Total liabilities |
$ |
$ | $ | $ |
||||||||||||
(1) |
Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
December 31, 2019 |
||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
Liabilities |
||||||||||||||||
Policyholder account balances: |
||||||||||||||||
GMWB embedded derivatives (1) |
$ | $ | $ | $ | ||||||||||||
Fixed index annuity embedded derivatives |
||||||||||||||||
Indexed universal life embedded derivatives |
||||||||||||||||
Total policyholder account balances |
||||||||||||||||
Derivative liabilities: |
||||||||||||||||
Interest rate swaps |
||||||||||||||||
Other foreign currency contracts |
||||||||||||||||
Total derivative liabilities |
||||||||||||||||
Total liabilities |
$ |
$ | $ | $ |
||||||||||||
(1) |
Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
Beginning balance as of January 1, 2020 |
Total realized and unrealized (gains) losses |
Ending balance as of March 31, 2020 |
Total (gains) losses attributable to liabilities still held |
|||||||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) |
Included in net (income) loss |
Included in OCI |
Purchases |
Sales |
Issuances |
Settlements |
Transfer into Level 3 |
Transfer out of Level 3 |
Included in net (income) loss |
Included in OCI |
||||||||||||||||||||||||||||||||||||||
Policyholder account balances: |
||||||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded (1) |
$ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||
Fixed index annuityembedded derivatives |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||
Indexed universal life embedded derivatives |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Total policyholder account balances |
( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
Total Level 3 liabilities |
$ | $ | $ | $ | $ | $ | $ | ( |
) | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
(1) |
Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
Beginning balance as of January 1, 2019 |
Total realized and unrealized (gains) losses |
Ending balance as of March 31, 2019 |
Total (gains) losses included in net (income) loss attributable to liabilities still held |
|||||||||||||||||||||||||||||||||||||||||
(Amounts in millions) |
Included in net (income) loss |
Included in OCI |
Purchases |
Sales |
Issuances |
Settlements |
Transfer into Level 3 |
Transfer out of Level 3 |
||||||||||||||||||||||||||||||||||||
Policyholder account balances: |
||||||||||||||||||||||||||||||||||||||||||||
GMWB embedded (1) |
$ | $ | ( |
) | $ | $ | $ | $ | $ | $ | $ | $ | $ | ( |
) | |||||||||||||||||||||||||||||
Fixed index annuity |
( |
) | ||||||||||||||||||||||||||||||||||||||||||
Indexed universal life |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Total policyholder |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||
Total Level 3 liabilities |
$ | $ | ( |
) | $ | $ | $ | $ | $ | ( |
) | $ | $ | $ | $ | ( |
) | |||||||||||||||||||||||||||
(1) |
Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. |
(Amounts in millions) |
2020 |
2019 |
||||||
Total realized and unrealized (gains) losses included in net (income) loss: |
||||||||
Net investment income |
$ | $ | ||||||
Net investment (gains) losses |
( |
) | ||||||
Total |
$ | $ | ( |
) | ||||
Total (gains) losses included in net (income) loss attributable to liabilities still held: |
||||||||
Net investment income |
$ | $ | ||||||
Net investment (gains) losses |
( |
) | ||||||
Total |
$ | $ | ( |
) | ||||
(Amounts in millions) |
Valuation technique |
Fair value |
Unobservable input |
Range |
Weighted-average (1) |
|||||||||||||||
Policyholder account balances: |
||||||||||||||||||||
Withdrawal utilization rate |
||||||||||||||||||||
Lapse rate |
||||||||||||||||||||
Non-performance risk (credit spreads) |
- |
|||||||||||||||||||
GMWB embedded (2) |
$ |
Equity index volatility |
- |
|||||||||||||||||
Fixed index annuity embedded |
$ |
Expected future interest credited |
- |
|||||||||||||||||
Indexed universal life embedded |
$ |
Expected future interest credited |
- |
(1) |
Unobservable inputs weighted by the policyholder account balances associated with the instrument. |
(2) |
Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. The unobservable inputs associated with GMWB embedded derivatives are not interrelated and therefore, a directional change in one input will not affect the other inputs. |
March 31, 2020 |
||||||||||||||||||||||||
Notional amount |
Carrying amount |
Fair value |
||||||||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
||||||||||||||||||||
Assets: |
||||||||||||||||||||||||
Commercial mortgage loans |
(1 |
) |
$ | $ | $ | $ | $ | |||||||||||||||||
Other invested assets |
(1 |
) |
||||||||||||||||||||||
Liabilities: |
||||||||||||||||||||||||
Long-term borrowings |
(1 |
) |
||||||||||||||||||||||
Investment contracts |
(1 |
) |
||||||||||||||||||||||
Other firm commitments: |
||||||||||||||||||||||||
Commitments to fund limited partnerships |
||||||||||||||||||||||||
Commitments to fund bank loan investments |
||||||||||||||||||||||||
Ordinary course of business lending commitments |
(1) |
These financial instruments do not have notional amounts. |
December 31, 2019 |
||||||||||||||||||||||||
Notional amount |
Carrying amount |
Fair value |
||||||||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
||||||||||||||||||||
Assets: |
||||||||||||||||||||||||
Commercial mortgage loans |
(1 |
) |
$ | |
$ | |
$ | |
$ | |
$ | |
||||||||||||
Other invested assets |
(1 |
) |
|
|
|
|
|
|||||||||||||||||
Liabilities: |
||||||||||||||||||||||||
Long-term borrowings |
(1 |
) |
|
|
|
|
|
|||||||||||||||||
Non-recourse funding obligations |
(1 |
) |
|
|
|
|
|
|||||||||||||||||
Investment contracts |
(1 |
) |
|
|
|
|
|
|||||||||||||||||
Other firm commitments: |
||||||||||||||||||||||||
Commitments to fund limited partnerships |
|
|
|
|
|
|
||||||||||||||||||
Commitments to fund bank loan investments |
|
|
|
|
|
|
||||||||||||||||||
Ordinary course of business lending commitments |
|
|
— |
|
|
|
(1) |
These financial instruments do not have notional amounts. |
|
As of or for the three months ended |
|||||||
(Amounts in millions) |
2020 |
2019 |
||||||
Beginning balance |
$ | |
$ | |
||||
Less reinsurance recoverables |
( |
) | ( |
) | ||||
Net beginning balance |
|
|
||||||
Incurred related to insured events of: |
||||||||
Current year |
|
|
||||||
Prior years |
( |
) | ( |
) | ||||
Total incurred |
|
|
||||||
Paid related to insured events of: |
||||||||
Current year |
( |
) | ( |
) | ||||
Prior years |
( |
) | ( |
) | ||||
Total paid |
( |
) | ( |
) | ||||
Interest on liability for policy and contract claims |
|
|
||||||
Foreign currency translation |
( |
) | |
|||||
Net ending balance |
|
|
||||||
Add reinsurance recoverables |
|
|
||||||
Ending balance |
$ | |
$ | |
||||
(Amounts in millions) |
||||
Allowance for credit losses: |
||||
Beginning balance |
$ | |
||
Cumulative effect of change in accounting |
|
|||
Provision |
|
|||
Write-offs |
|
|||
Recoveries |
|
|||
Ending balance |
$ | |
||
(Amounts in millions) |
Collateralized |
Non-collateralized |
Total |
|||||||||
Credit rating: |
||||||||||||
A++ |
$ | |
$ | |
$ | |
||||||
A+ |
|
|
|
|||||||||
A |
|
|
|
|||||||||
A- |
|
|
|
|||||||||
B+ |
|
|
|
|||||||||
Not rated |
|
|
|
|||||||||
Total reinsurance recoverabl e |
$ | |
$ | |
$ | |
||||||
(Amounts in millions) |
March 31, 2020 |
December 31, 2019 |
||||||
Genworth Holdings (1) |
||||||||
7.70% Senior Notes, due 2020 |
$ | $ | ||||||
7.20% Senior Notes, due 2021 |
||||||||
7.625% Senior Notes, due 2021 |
||||||||
4.90% Senior Notes, due 2023 |
||||||||
4.80% Senior Notes, due 2024 |
||||||||
6.50% Senior Notes, due 2034 |
||||||||
Floating Rate Junior Subordinated Notes, due 2066 |
||||||||
Subtotal |
||||||||
Bond consent fees |
( |
) | ( |
) | ||||
Deferred borrowing charges |
( |
) | ( |
) | ||||
Total Genworth Holdings |
||||||||
Australia (2) |
||||||||
Floating Rate Junior Subordinated Notes, due 2025 |
||||||||
Total Australia |
||||||||
Total |
$ | $ | ||||||
(1) |
We have the option to redeem all or a portion of the senior notes at any time with notice to the noteholders at a price equal to the greater of 100% of principal or the sum of the present value of the remaining scheduled payments of principal and interest discounted at the then-current treasury rate plus an applicable spread. |
(2) |
Subordinated floating rate notes issued by Genworth Financial Mortgage Insurance Pty Limited, our indirect majority-owned subsidiary, who has the option to redeem the notes at face value beginning on July 3, 2020, subject to the Australian Prudential Regulation Authority’s prior written approval. |
Three months ended March 31, |
||||||||
2020 |
2019 |
|||||||
Statutory U.S. federal income tax rate |
% | % | ||||||
Increase (reduction) in rate resulting from: |
||||||||
Swaps terminated prior to the TCJA (1) |
( |
) | ||||||
Effect of foreign operations |
||||||||
Stock-based compensation |
( |
) | ||||||
Nondeductible expenses |
( |
) | ||||||
Other, net |
( |
) | ||||||
Effective rate |
% | % | ||||||
(1) |
Tax Cuts and Jobs Act |
Three months ended March 31, |
||||||||
(Amounts in millions) |
2020 |
2019 |
||||||
Revenues: |
||||||||
U.S. Mortgage Insurance segment |
$ | $ | ||||||
Australia Mortgage Insurance segment |
||||||||
U.S. Life Insurance segment: |
||||||||
Long-term care insurance |
||||||||
Life insurance |
||||||||
Fixed annuities |
||||||||
U.S. Life Insurance segment |
||||||||
Runoff segment |
||||||||
Corporate and Other activities |
( |
) | ||||||
Total revenues |
$ | $ | ||||||
Three months ended March 31, |
||||||||
(Amounts in millions) |
2020 |
2019 |
||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | ( |
) | $ | ||||
Add: net income (loss) from continuing operations attributable to noncontrolling interests |
( |
) | ||||||
Add: net income from discontinued operations attributable to noncontrolling interests |
||||||||
Net income (loss) |
( |
) | ||||||
Less: income from discontinued operations, net of taxes |
||||||||
Income (loss) from continuing operations |
( |
) | ||||||
Less: net income (loss) from continuing operations attributable to noncontrolling interests |
( |
) | ||||||
Income (loss) from continuing operations available to Genworth Financial, Inc.’s |
( |
) | ||||||
Adjustments to income (loss) from continuing operations available to Genworth |
||||||||
Net investment (gains) losses, net (1) |
( |
) | ||||||
Losses on early extinguishment of debt |
||||||||
Expenses related to restructuring |
||||||||
Taxes on adjustments |
( |
) | ||||||
Adjusted operating income available to Genworth Financial, Inc.’s |
$ | $ | ||||||
(1) |
For the three months ended March 31, 2020 and 2019, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $( |
Three months ended March 31, |
||||||||
(Amounts in millions) |
2020 |
2019 |
||||||
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: |
||||||||
U.S. Mortgage Insurance segment |
$ | $ | ||||||
Australia Mortgage Insurance segment |
||||||||
U.S. Life Insurance segment: |
||||||||
Long-term care insurance |
( |
) | ||||||
Life insurance |
( |
) | ( |
) | ||||
Fixed annuities |
||||||||
U.S. Life Insurance segment |
( |
) | ( |
) | ||||
Runoff segment |
( |
) | ||||||
Corporate and Other activities |
( |
) | ( |
) | ||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
(Amounts in millions) |
March 31, 2020 |
December 31, 2019 |
||||||
Assets: |
||||||||
U.S. Mortgage Insurance segment |
$ | $ | ||||||
Australia Mortgage Insurance segment |
||||||||
U.S. Life Insurance segment |
||||||||
Runoff segment |
||||||||
Corporate and Other activities |
||||||||
Total assets |
$ | $ | ||||||
(Amounts in millions) |
Net unrealized investment gains (losses) (1) |
Derivatives qualifying as hedges (2) |
Foreign currency translation and other adjustments |
Total |
||||||||||||
Balances as of January 1, 2020 |
$ | $ | $ | ( |
) | $ | ||||||||||
OCI before reclassifications |
( |
) |
( |
) | ||||||||||||
Amounts reclassified from (to) OCI |
( |
) |
( |
) |
( |
) | ||||||||||
Current period OCI |
( |
) |
( |
) | ||||||||||||
Balances as of March 31, 2020 before noncontrolling interests |
( |
) | ||||||||||||||
Less: change in OCI attributable to noncontrolling interests |
( |
) |
( |
) | ( |
) | ||||||||||
Balances as of March 31, 2020 |
$ | $ | $ | ( |
) | $ | ||||||||||
(1) |
Net of adjustments to DAC, present value of future profits, sales inducements and benefit reserves. See note 4 for additional information. |
(2) |
See note 5 for additional information. |
(Amounts in millions) |
Net unrealized investment gains (losses) (1) |
Derivatives qualifying as hedges (2) |
Foreign currency translation and other adjustments |
Total |
||||||||||||
Balances as of January 1, 2019 |
$ | $ | $ | ( |
) | $ | ||||||||||
OCI before reclassifications |
||||||||||||||||
Amounts reclassified from (to) OCI |
( |
) |
( |
) |
( |
) | ||||||||||
Current period OCI |
||||||||||||||||
Balances as of March 31, 2019 before noncontrolling interests |
( |
) | ||||||||||||||
Less: change in OCI attributable to noncontrolling interests |
||||||||||||||||
Balances as of March 31, 2019 |
$ | $ | $ | ( |
) | $ | ||||||||||
(1) |
Net of adjustments to DAC, present value of future profits, sales inducements and benefit reserves. See note 4 for additional information. |
(2) |
See note 5 for additional information. |
Amount reclassified from accumulated other comprehensive income |
Affected line item in the consolidated statements of income |
|||||||||||
Three months ended March 31, |
||||||||||||
(Amounts in millions) |
2020 |
2019 |
||||||||||
Net unrealized investment (gains) losses: |
||||||||||||
Unrealized (gains) losses on investments (1) |
$ | ( |
) | $ | ( |
) | Net investment (gains) losses |
|||||
(Provision) benefit for income taxes |
Provision for income taxes |
|||||||||||
Total |
$ | ( |
) | $ | ( |
) | ||||||
Derivatives qualifying as hedges: |
||||||||||||
Interest rate swaps hedging assets |
$ | ( |
) | $ | ( |
) | Net investment income |
|||||
Interest rate swaps hedging assets |
( |
) | ( |
) | Net investment (gains) losses |
|||||||
Benefit for income taxes |
Provision for income taxes |
|||||||||||
Total |
$ | ( |
) | $ | ( |
) | ||||||
(1) |
Amounts exclude adjustments to DAC, present value of future profits, sales inducements and benefit reserves. |
(Amounts in millions) |
||||
Revenues: |
||||
Premiums |
$ | |||
Net investment income |
||||
Net investment gains (losses) |
( |
) | ||
Total revenues |
||||
Benefits and expenses: |
||||
Benefits and other changes in policy reserves |
||||
Acquisition and operating expenses, net of deferrals |
||||
Amortization of deferred acquisition costs and intangibles |
||||
Interest expense (1) |
||||
Total benefits and expenses |
||||
Income before income taxes (2) |
||||
Provision for income taxes |
||||
Income from discontinued operations, net of taxes |
||||
Less: net income from discontinued operations |
||||
Income from discontinued operations available to |
$ | |||
(1) |
Interest on debt assumed by Brookfield and interest on debt that was repaid as a result of the sale of Genworth Canada was allocated and reported in discontinued operations. A senior secured term loan facility (“Term Loan”), owed by Genworth Holdings and secured by GFIH’s ownership interest in Genworth Canada’s outstanding common shares, was repaid in connection with the close of the Genworth Canada sale. Accordingly, interest expense related to the Term Loan of $ |
(2) |
The three months ended March 31, 2019 includes pre-tax income from discontinued operations available to Genworth Financial, Inc.’s common stockholders of $ |
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
• | risks related to the proposed transaction with China Oceanwide geo-political environment, or that one or more regulators may rescind or fail to extend existing approvals, or that the revocation by one regulator of approvals will lead to the revocation of approvals by other regulators; the parties’ inability to obtain any necessary regulatory approvals, clearances or extensions for the post-closing capital plan; the risk that a condition to the closing of the transaction may not be satisfied or that a condition to closing that is currently satisfied may not remain satisfied due to the delay in closing the transaction or that the parties will be unable to agree upon a closing date following receipt of all regulatory approvals and clearances; the risks regarding the ongoing availability of any required financing; the risk that existing and potential legal proceedings may be instituted in connection with the transaction that may delay the transaction, make it more costly or ultimately preclude it; the risk that the proposed transaction disrupts our current plans and operations as a result of the announcement and consummation of the transaction; certain restrictions during the pendency of the transaction that may impact our ability to pursue certain business opportunities or strategic transactions; continued availability of capital and financing to us before, or in the absence of, the consummation of the transaction; further rating agency actions and downgrades in our credit or financial strength ratings; changes in applicable laws or regulations; our ability to recognize the anticipated benefits of the transaction; the amount of the costs, fees, expenses |
and other charges related to the transaction; the risks related to diverting management’s attention from our ongoing business operations; our ability to attract, recruit, retain and motivate current and prospective employees may be adversely affected; and potential adverse reactions or changes to our business relationships with clients, employees, suppliers or other parties or other business uncertainties resulting from the announcement of the transaction or during the pendency of the transaction, including but not limited to such changes that could affect our financial performance; |
• | strategic risks in the event the proposed transaction with China Oceanwide is not consummated COVID-19 delay or hinder alternative transactions or otherwise make alternative plans less attractive; our inability to attract buyers for any businesses or other assets we may seek to sell, or securities we may seek to issue, in each case, in a timely manner and on anticipated terms; failure to obtain any required regulatory, stockholder and/or noteholder approvals or consents for such alternative strategic plans, or our challenges changing or being more costly or difficult to successfully address than currently anticipated or the benefits achieved being less than anticipated; inability to achieve anticipated cost-savings in a timely manner; adverse tax or accounting charges; and our ability to increase the capital needed in our mortgage insurance businesses in a timely manner and on anticipated terms, including through business performance, reinsurance or similar transactions, asset sales, securities offerings or otherwise, in each case as and when required; |
• | risks relating to estimates, assumptions and valuations COVID-19; inaccurate models; deviations from our estimates and actuarial assumptions or other reasons in our long-term care insurance, life insurance and/or annuity businesses; accelerated amortization of deferred acquisition costs (“DAC”) and present value of future profits (“PVFP”) (including as a result of any future changes we may make to our assumptions, methodologies or otherwise in connection with periodic or other reviews); adverse impact on our financial results as a result of projected profits followed by projected losses (as is currently the case with our long-term care insurance business); adverse impact on our results of operations, including the outcome of our reviews of the premium earnings pattern for our mortgage insurance businesses; and changes in valuation of fixed maturity and equity securities; |
• | risks relating to economic, market and political conditions COVID-19; interest rates and changes in rates have adversely impacted, and may continue to materially adversely impact, our business and profitability; deterioration in economic conditions or a decline in home prices that adversely affect our loss experience in mortgage insurance; political and economic instability or changes in government policies; and fluctuations in foreign currency exchange rates and international securities markets; |
• | regulatory and legal risks COVID-19, and other insurance, regulatory or corporate law restrictions; the inability to successfully seek in-force rate action increases (including increased |
premiums and associated benefit reductions) in our long-term care insurance business, including as a result of COVID-19; adverse change in regulatory requirements, including risk-based capital; changes in regulations adversely affecting our Australian mortgage insurance business; inability to continue to maintain the private mortgage insurer eligibility requirements (“PMIERs”); the impact on capital levels of increased delinquencies caused by COVID-19; inability of our U.S. mortgage insurance subsidiaries to meet minimum statutory capital requirements; the influence of Federal National Mortgage Association (“Fannie Mae”), Federal Home Loan Mortgage Corporation (“Freddie Mac”) and a small number of large mortgage lenders on the U.S. mortgage insurance market and adverse changes to the role or structure of Fannie Mae and Freddie Mac; adverse changes in regulations affecting our mortgage insurance businesses; inability to continue to implement actions to mitigate the impact of statutory reserve requirements; changes in tax laws; and changes in accounting and reporting standards; |
• | liquidity, financial strength ratings, credit and counterparty risks COVID-19; continued availability of capital and financing; future adverse rating agency actions, including with respect to rating downgrades or potential downgrades or being put on review for potential downgrade, all of which could have adverse implications for us, including with respect to key business relationships, product offerings, business results of operations, financial condition and capital needs, strategic plans, collateral obligations and availability and terms of hedging, reinsurance and borrowings; defaults by counterparties to reinsurance arrangements or derivative instruments; defaults or other events impacting the value of our fixed maturity securities portfolio; and defaults on our commercial mortgage loans or the mortgage loans underlying our investments in commercial mortgage-backed securities and volatility in performance; |
• | operational risks shelter-in-place or other governmental restrictions imposed as a result of COVID-19; reliance on, and loss of, key customer or distribution relationships; competition, including in our mortgage insurance businesses from government and government-owned and government-sponsored enterprises (“GSEs”) offering mortgage insurance; the design and effectiveness of our disclosure controls and procedures and internal control over financial reporting may not prevent all errors, misstatements or misrepresentations; and failure or any compromise of the security of our computer systems, disaster recovery systems and business continuity plans and failures to safeguard, or breaches of, its confidential information; |
• | insurance and product-related risks in-force long-term care insurance policies, in each case, as currently anticipated and as may be required from time to time in the future (including as a result of a delay or failure to obtain any necessary regulatory approvals, including as a result of COVID-19, or unwillingness or inability of policyholders to pay increased premiums and/or accept reduced benefits), including to offset any negative impact on our long-term care insurance margins; availability, affordability and adequacy of reinsurance to protect us against losses; decreases in the volume of high loan-to-value mortgage originations or increases in mortgage insurance cancellations; increases in the use of alternatives to private mortgage insurance and reductions in the level of coverage selected; potential liabilities in connection with our U.S. contract underwriting services; and medical advances, such as genetic research and diagnostic imaging, and related legislation that impact policyholder behavior in ways adverse to us; |
• | other risks man-made disasters or a pandemic, such as COVID-19, could materially adversely affect our financial condition and results of operations. |
• | COVID-19 has disrupted the global economy and financial markets, business operations, and consumer behavior and confidence. Large scale disruption in the U.S. economy is leaving several industries non-operational through state and federal mandated shutdowns in an effort to contain the spread of COVID-19. While all states have been impacted, certain geographies have been disproportionately impacted by COVID-19 either through the spread of the virus or the severity of the mitigation steps taken to control its spread. Unemployment claims have increased to historic levels with approximately 30 million Americans filing for unemployment claims through late April 2020, reducing consumer confidence to its lowest level since the 2008 financial crisis. |
• | During and following the first quarter of 2020, signs have pointed to a global recession as a result of COVID-19. Other signs of a potential global recession include negative monthly inflation, historically low retail sales and a dramatic decrease in industrial production. |
• | In response to the economic headwinds and COVID-19, the U.S. Federal Reserve reduced interest rates by 150 basis points during the first quarter of 2020. The U.S. Federal Reserve’s interest rate reductions, along with expectations of negative growth drove U.S. Treasury yields down approximately 100 to 150 basis points, with the decline in short-term interest rates outpacing the decline in long-term interest rates. |
• | The global economic slowdown has driven other global central banks and foreign governments to take similar accommodative actions to stabilize capital markets and implement fiscal stimulus to support their respective domestic economies. Credit markets responded to COVID-19 and the subsequent economic downturn with widening of credit spreads to recessionary levels. |
• |
Stay at home orders and partial economic shutdowns are expected to place strain on earnings and corporate balance sheets for the next two quarters and possibly for the remainder of 2020, which when combined with forced liquidations as a result of liquidity strains, further contributed to the credit spread widening. |
• | A crude oil price war triggered by supply and demand imbalance decreased crude oil prices over 60% in the first quarter of 2020 and contributed to additional credit spread widening and financial pressure to the energy sector. |
• | The U.S. Federal Reserve announced new quantitative easing programs to help support credit markets, including a $2.3 trillion program that includes a $750 billion corporate credit facility to purchase investment grade and certain high yield corporate securities, among other facilities to support the loan, municipal and structured markets. |
• | As a result of COVID-19, our U.S. mortgage insurance business has already begun to experience declines in investment valuations and declines in persistency rates from prevailing lower interest rates. Additionally, we could experience asset impairments, increases in delinquent loans and paid claims, lower future new insurance written levels, increases to our capital requirements and pressure on our capital sufficiency ratios. |
• | The recently signed Coronavirus Aid, Relief, and Economic Security (“CARES”) Act along with programs announced by the Federal Housing Finance Agency (“FHFA”), Fannie Mae, and Freddie Mac all include provisions to offer forbearance to borrowers facing hardship due to COVID-19. In addition, the CARES act, the FHFA, and many local governments announced moratoriums on foreclosures and evictions for 60 days, beginning March 18, 2020. |
• | The result of a large response to forbearance programs and an extended time to remain in forbearance or enter modification means we expect an elevated level of delinquencies reported to us and for those loans to remain in a delinquent status for an extended period. The result will likely decrease our Private Mortgage Insurer Eligibility Requirements (“PMIERs”) required asset levels with which we must comply to remain an eligible insurer for Fannie Mae and Freddie Mac. We and the other U.S. mortgage insurers are currently working closely with the FHFA, Fannie Mae, and Freddie Mac to determine the proper treatment of these COVID-19 delinquencies, which may cure at a higher rate than traditional delinquencies should economic activity quickly return to pre-COVID-19 levels. Severity of loss on loans that do go to claim, however, may be negatively impacted by the extended forbearance timeline, the associated elevated expenses such as accumulated interest and home price depreciation, if any. |
• | We expect our PMIERs sufficiency ratio to decrease as a result of incremental delinquencies directly or indirectly related to COVID-19. Given the expectation for a decrease in our PMIERs sufficiency ratio prospectively as a result of new delinquencies stemming from COVID-19, we intend to preserve PMIERs available assets and our U.S. mortgage insurance business may not provide dividends in 2020. The amount and timing of dividends will be reevaluated later in 2020 and will depend on the economic recovery from COVID-19. |
• | COVID-19 is having a significant impact on the Australian economy. To curb the spread of the virus, the Australian government restricted the movement of people within the country by implementing social distancing measures and shutting down all non-essential businesses. This has resulted in major disruptions to economic activity across the country. |
• | Many of our lender customers have announced initiatives that allow affected homeowners the option to defer their repayments for a period of up to six months. Homeowners that participate in such lender hardship programs will not be reported as delinquent during this time. In addition, the Australian |
Prudential Regulation Authority (“APRA”) has provided guidance to insurers asking them to limit discretionary capital distributions, including dividends, until the impact of COVID-19 is better understood to ensure that they have sufficient capital capacity to continue essential functions such as underwriting new insurance. Given the uncertainty, we cannot predict the ultimate impact that COVID-19 will have on our mortgage insurance business in Australia. |
• | Given the potential economic impacts of COVID-19, our mortgage insurance business in Australia could be subject to a ratings downgrade in the future. If that occurs, the business will work with its customers to demonstrate its credit strength and endeavor to avoid termination of any existing contracts. |
• | As a result of potential impacts on capital levels, we may not receive dividends or other returns of capital from our mortgage insurance business in Australia for the remainder of 2020. The amount and timing of dividends will be reevaluated later in 2020 and will depend on the economic recovery from COVID-19. |
• | The most significant impacts in our U.S. life insurance businesses from COVID-19 are related to the current low interest rate environment and equity market volatility/declines, and may also be impacted by future mortality and morbidity experience. |
• | Our long-term care insurance product reserves could be negatively impacted by the current low interest rate environment, particularly as it relates to loss recognition testing and asset adequacy analysis. In our long-term care insurance products, we would expect some degree of higher mortality during COVID-19 which would have a favorable impact on claims. We are not expecting COVID-19 to drive higher claims frequency in our long-term care insurance business and we may observe temporarily reduced claim incidence while shelter-in-place and social distancing protocols are in effect. |
• | Our U.S. life insurance companies are dependent on the approval of actuarially justified in-force rate actions in our long-term care insurance business, including those rate actions which were previously filed and are currently pending review and approval. We could experience delays in receiving approvals of these in-force rate actions during COVID-19. |
• | The low interest rate environment and declining equity markets have adversely impacted earnings in our fixed annuity products; however, if mortality is higher in future months, it could benefit earnings in these products in future quarters. Conversely, higher mortality rates could lower profitability in our life insurance products. |
• | In our U.S life insurance companies, we will comply with guidance issued by certain insurance regulators, such as mandates that policies cannot be lapsed or cancelled if premiums are not paid or requirements to provide extensions of grace periods during the COVID-19 outbreak. |
• | The low interest rate environment and declining equity markets have materially adversely impacted earnings in our variable annuity products; however, if mortality is higher in future months, it could benefit earnings in these products in future quarters. |
• | While certain states currently have mandates in place that policies cannot be lapsed, we do not expect a significant impact on our Runoff segment. There is no requirement to pay premiums in the majority of our variable annuity contracts and benefits would adjust contractually based on actual premiums paid in these products. |
• | We could see additional losses and declines in statutory risk-based capital driven by increases to the required capital supporting our variable annuity products, as a result of the decline in equity markets and low interest rates. |
• | We are actively monitoring our investment portfolio, including asset valuations impacted by the spread of COVID-19 and the resulting economic disruption. Our investment portfolio is primarily comprised of investment grade fixed maturity securities, with approximately 58% rated “A” and above. The carrying value of our investment portfolio as of March 31, 2020 and December 31, 2019 was $70.7 billion and $71.2 billion, respectively, of which 84% and 85%, respectively, was invested in fixed maturity securities. |
• | In March 2020, due in large part to COVID-19, we experienced significant credit spread widening, principally in our U.S. and non-U.S. corporate bond investments. The credit spread widening resulted in approximately $2.5 billion of unrealized investment losses, partially offset by approximately $0.8 billion of unrealized investment gains in our U.S. government bond investments principally due to the dramatic decrease in interest rates. The net unrealized investment loss of approximately $1.7 billion related to our fixed maturity securities was recorded as a part of accumulated other comprehensive income (loss) as of March 31, 2020 and had no impact on earnings in the first quarter of 2020. |
• | We routinely monitor our investment portfolio for possible ratings downgrades and other signs of distress that could be indicators of impairment. Our monitoring includes identifying assets susceptible to the efforts to contain the spread of COVID-19, including close inspection of investments in industries directly impacted, such as travel, energy, leisure, lodging and auto. Our monitoring also includes inspection of other credit risk attributes, such as high leverage, supply chain interruptions and service disruptions/stoppages. |
• | Our investment portfolio is less exposed to equity market volatility; however, we have seen a dramatic decline in the fair value of our equity securities and limited partnership investments which was recognized as a loss of $59 million in the first quarter of 2020. |
• | The CARES Act includes numerous measures to assist businesses, including temporary changes to income and non-income-based tax laws, permitting employers to delay contributions to defined benefit pension plans until January 1, 2021 and allowing financial institutions to suspend U.S. GAAP guidance related to loan modifications considered to be troubled debt restructurings. We are not included among the entities permitted to suspend U.S. GAAP guidance related to loan modifications considered to be troubled debt restructurings or temporarily defer new accounting guidance on expected credit losses. Accordingly, we adopted the new guidance on January 1, 2020 as discussed further in note 2 in our unaudited condensed consolidated financial statements under “Part 1—Item 1—Financial Statements.” |
• | The most significant changes pertaining to temporary income and non-income-based tax laws include: |
• | eliminating the 80% of taxable income limitation, allowing corporate entities to fully utilize net operating loss (“NOL”) carryforwards to offset taxable income in 2018, 2019 or 2020 (the 80% limitation is reinstated for tax years after 2020); |
• | allowing NOLs originating in 2018, 2019 or 2020 to be carried back five years; |
• | increasing the net interest expense deduction limit from 30% to 50% of adjusted taxable income for tax years beginning January 1, 2019 and 2020; and |
• | a non-income tax provision, allowing payments of the employer share of social security payroll taxes that are not Medicare related and would otherwise be due from the date of enactment through December 31, 2020 to be paid in two installments at the end of 2021 and 2022. |
• | We have applied the temporary NOL changes to our current period tax provision reflecting our most likely tax return filing position. |
• | We are actively taking preventive measures to mitigate the risk of operational disruption, which includes identifying potential impacts on our consumers, employees and vendors. Our business continuity plans allow us to continue operations of critical functions, such as entering client orders, completing customer transactions, paying claims and providing clients access to their accounts and policy values. Our business continuity plans also consider workforce continuity. |
• | In addition, we are in discussions with key suppliers on their business continuity status as it relates to COVID-19. Our most critical suppliers are reporting on their actions to keep facilities clean, limit workforce in their facilities, and moving to a remote work from home workforce. For our suppliers who interact with customers, we do have a few that are reporting limitations or the inability to service designated areas due to local and state government shelter in place or restrictions on essential activities. Currently, affected areas are primarily located in India and the Philippines, where the ability to work from home is impacted due to country-wide infrastructure and other limitations. To mitigate this, we are leveraging our business continuity plans to ensure critical activities are still being conducted by leveraging supplier remote work capabilities and redeploying internal resources. |
• | For our customers, we have employed a range of activities to share our continued commitment to serving them through this unprecedented situation, along with any process changes that have resulted from our work-from-home status or other community mandates. These communications include, but are not limited to, email communication, mailing letters and publishing a webpage on “COVID-19 Preparedness” on genworth.com. We continue to provide customer service to our policyholders during this uncertain time and will work with our policyholders if they contact us with questions or concerns regarding their policies. |
• | We have performed an analysis of our internal control environment and believe the impact of the current remote work environment as a result of COVID-19 has not to date materially affected our ability to maintain effective controls and procedures. |
• | Genworth Holdings maintains a continuous process for evaluating group-level liquidity, under normal and stressed environments. In light of COVID-19 emergence, we are currently developing additional stress scenarios to evaluate potential impacts to our businesses and Genworth Holdings. We are modeling various stress scenarios given the potential lack of near-term dividends from our subsidiaries. |
• | Currently, we believe Genworth Holdings has adequate liquidity and options available to address current liquidity needs, if they arise, such as cash on hand, a potential issuance of debt at the holding company of our U.S. mortgage insurance subsidiary, or secured debt at Genworth Holdings. Genworth Holdings’ next debt maturity is February 2021. |
• | We also monitor the cash and highly liquid investment positions in each of our operating subsidiaries to ensure they will have the cash necessary to meet their obligations as they come due. Our businesses have liquidity options available to them, including Federal Home Loan Bank funding agreements and repurchase facilities, selling highly liquid securities and entering into new reinsurance arrangements. Given the options available, we believe Genworth Holdings and its operating subsidiaries will be able to meet the near-term liquidity demands given the current market impacts from COVID-19. For additional details on our overall liquidity and future dividend sources, see “—Liquidity and Capital Resources.” |
• | We had a net loss available to Genworth Financial, Inc.’s common stockholders of $66 million for the three months ended March 31, 2020 compared to net income available to Genworth Financial, Inc.’s common stockholders of $174 million for the three months ended March 31, 2019. Adjusted operating income available to Genworth Financial, Inc.’s common stockholders was $33 million and $95 million for the three months ended March 31, 2020 and 2019, respectively. |
• | Our U.S. Mortgage Insurance segment had adjusted operating income available to Genworth Financial, Inc.’s common stockholders of $148 million and $124 million for the three months ended March 31, 2020 and 2019, respectively. The increase was primarily attributable to higher premiums and an increase in investment income, partially offset by higher operating costs and losses in the current year. |
• | Our Australia Mortgage Insurance segment had adjusted operating income available to Genworth Financial, Inc.’s common stockholders of $9 million and $14 million for the three months ended March 31, 2020 and 2019, respectively. The decrease was primarily driven by lower earned premiums largely from portfolio seasoning and lower policy cancellations, partially offset by lower losses primarily from favorable aging of existing delinquencies in the current year. |
• | Our U.S. Life Insurance segment had an adjusted operating loss available to Genworth Financial, Inc.’s common stockholders of $70 million and $5 million for the three months ended March 31, 2020 and 2019, respectively. |
• | Our long-term care insurance business had adjusted operating income available to Genworth Financial, Inc.’s common stockholders of $1 million in the current year compared to an adjusted operating loss available to Genworth Financial, Inc.’s common stockholders of $20 million in the prior year. The increase to income in the current year from a loss in the prior year was primarily from $52 million of higher premiums and reduced benefits in the current year from in-force rate actions approved and implemented, a slightly favorable impact from benefit utilization rate updates in the current year compared to an unfavorable impact in the prior year and continued favorable development on prior year incurred but not reported claims. These increases were partially offset by higher frequency and severity of new claims in the current year. |
• | The adjusted operating loss available to Genworth Financial, Inc.’s common stockholders for our life insurance business increased $75 million mainly attributable to higher lapses primarily associated with our large 20-year term life insurance block entering its post-level premium period, higher reserves in our 10-year term universal life insurance block entering its post-level premium period during the premium grace period and from higher mortality in our universal and term life insurance products in the current year compared to the prior year. |
• | Adjusted operating income available to Genworth Financial, Inc.’s common stockholders decreased $11 million in our fixed annuities business predominantly from higher reserves and amortization of DAC in our fixed indexed annuities driven by unfavorable market changes in the current year, lower mortality in our single premium immediate annuities and a decrease in net spreads due to the runoff of the block. These decreases were partially offset by $13 million of |
unfavorable charges in connection with loss recognition testing in our fixed immediate annuity products in the prior year that did not recur. |
• | Our Runoff segment had an adjusted operating loss available to Genworth Financial, Inc.’s common stockholders of $13 million for the three months ended March 31, 2020 compared to adjusted operating income available to Genworth Financial, Inc.’s common stockholders of $20 million for the three months ended March 31, 2019. The decrease to a loss in the current year from income in the prior year was predominantly from the decline in equity markets and interest rates in the current year. |
• | Corporate and Other Activities had an adjusted operating loss available to Genworth Financial, Inc.’s common stockholders of $41 million and $58 million for the three months ended March 31, 2020 and 2019, respectively. The decrease in the loss was principally related to lower interest expense and higher investment income in the current year. |
• | PMIERs compliance |
• | New insurance written. in-force through higher new insurance written, which increased 86% in the first quarter of 2020 compared to the first quarter of 2019. The increase was primarily due to higher mortgage refinancing originations and our higher estimated market share in the current year. |
• | Existing Delinquencies. |
• | Regulatory capital. |
• | Impact from bushfires. |
• | In-force rate actions in our long-term care insurance business. in-force rate action filings, we received 32 filing approvals from 15 states in the first quarter of 2020, representing a weighted-average increase of 35% on approximately $130 million in annualized in-force premiums, or approximately $45 million of incremental annual premiums. |
• | Redemption of Genworth Holdings’ June 2020 senior notes pre-tax loss of $9 million. The senior notes were fully redeemed with a cash payment of $409 million, comprised of the outstanding principal balance of $397 million, accrued interest of $3 million and a make-whole premium of $9 million. |
• | Partial Repurchases of Genworth Holdings’ 2021 senior notes pre-tax gain of $1 million and paid accrued interest thereon. In April 2020, Genworth Holdings repurchased an additional $36 million principal amount of its senior notes with 2021 maturity dates for a pre-tax gain of $2 million. |
• | Redemption of non-recourse funding obligations. non-recourse funding obligations due in 2050. The early redemption resulted in a pre-tax loss of $4 million from the write-off of deferred borrowing costs. |
• | Intercompany note maturity |
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2020 |
2019 |
2020 vs. 2019 |
|||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | 1,015 |
$ | 988 |
$ | 27 |
3 |
% | ||||||||
Net investment income |
793 |
794 |
(1 |
) | — |
% | ||||||||||
Net investment gains (losses) |
(152 |
) | 75 |
(227 |
) | NM |
(1) | |||||||||
Policy fees and other income |
181 |
187 |
(6 |
) | (3 |
)% | ||||||||||
Total revenues |
1,837 |
2,044 |
(207 |
) | (10 |
)% | ||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
1,361 |
1,282 |
79 |
6 |
% | |||||||||||
Interest credited |
141 |
147 |
(6 |
) | (4 |
)% | ||||||||||
Acquisition and operating expenses, net of deferrals |
249 |
237 |
12 |
5 |
% | |||||||||||
Amortization of deferred acquisition costs and intangibles |
116 |
81 |
35 |
43 |
% | |||||||||||
Interest expense |
52 |
60 |
(8 |
) | (13 |
)% | ||||||||||
Total benefits and expenses |
1,919 |
1,807 |
112 |
6 |
% | |||||||||||
Income (loss) from continuing operations before income taxes |
(82 |
) | 237 |
(319 |
) | (135 |
)% | |||||||||
Provision (benefit) for income taxes |
(10 |
) | 69 |
(79 |
) | (114 |
)% | |||||||||
Income (loss) from continuing operations |
(72 |
) | 168 |
(240 |
) | (143 |
)% | |||||||||
Income from discontinued operations, net of taxes |
— |
62 |
(62 |
) | (100 |
)% | ||||||||||
Net income (loss) |
(72 |
) | 230 |
(302 |
) | (131 |
)% | |||||||||
Less: net income (loss) from continuing operations attributable to noncontrolling interests |
(6 |
) | 20 |
(26 |
) | (130 |
)% | |||||||||
Less: net income from discontinued operations attributable to noncontrolling interests |
— |
36 |
(36 |
) | (100 |
)% | ||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | (66 |
) | $ | 174 |
$ | (240 |
) | (138 |
)% | ||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||
Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders |
$ | (66 |
) | $ | 148 |
$ | (214 |
) | (145 |
)% | ||||||
Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders |
— |
26 |
(26 |
) | (100 |
)% | ||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | (66 |
) | $ | 174 |
$ | (240 |
) | (138 |
)% | ||||||
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
|
• |
Our U.S. Mortgage Insurance segment increased $32 million mainly attributable to higher insurance in-force and an increase in policy cancellations in our single premium mortgage insurance product driven largely by higher mortgage refinancing, partially offset by lower average premium rates in the current year. |
• | Our U.S. Life Insurance segment increased $9 million. Our long-term care insurance business increased $14 million largely from $34 million of increased premiums in the current year from in-force rate actions approved and implemented, partially offset by policy terminations and policies entering paid-up status in the current year. Our life insurance business decreased $5 million mainly attributable to the continued runoff of our term life insurance products in the current year. |
• | Our Australia Mortgage Insurance segment decreased $14 million predominantly from portfolio seasoning and lower policy cancellations in the current year. The three months ended March 31, 2020 included a decrease of $4 million attributable to changes in foreign exchange rates. |
• | Our U.S. Life Insurance segment increased $61 million. Our long-term care insurance business increased $1 million principally from the aging of the in-force block (including higher frequency of new claims), higher incremental reserves of $39 million recorded in connection with an accrual for profits followed by losses and higher severity of new claims in the current year. These increases were mostly offset by a higher favorable impact of $34 million from reduced benefits in the current year related to in-force rate actions approved and implemented, a slightly favorable impact from benefit utilization rate updates in the current year compared to an unfavorable impact in the prior year and favorable development on prior year incurred but not reported claims. Our life insurance business increased $60 million primarily attributable to higher reserves in our 10-year term universal life insurance block entering its post-level premium period during the premium grace period and from higher mortality in our universal and term life insurance products in the current year compared to the prior year. Our fixed annuities business was flat as higher reserves in our fixed indexed annuities driven by unfavorable market changes in the current year and lower mortality in our single premium immediate annuities were offset by $17 million of higher reserves recorded in the prior year related to loss recognition testing in our fixed immediate annuity products that did not recur. |
|
• |
Our Runoff segment increased $19 million primarily attributable to higher guaranteed minimum death benefit (“GMDB”) reserves in our variable annuity products due to unfavorable equity market performance in the current year. |
|
• |
Our U.S. Mortgage Insurance segment increased $3 million largely from lower net benefits from cures and aging of existing delinquencies, partially offset by a decrease in new delinquencies and a lower average reserve on new delinquencies in the current year. |
• | Our Australia Mortgage Insurance segment decreased $4 million primarily from favorable aging of existing delinquencies in the current year. |
• | Corporate and Other activities increased $5 million mainly driven by a make-whole premium of $9 million related to the early redemption of Genworth Holdings’ senior notes originally scheduled to mature in June 2020 and higher employee-related expenses, partially offset by lower operating expenses in the current year. |
• | Our U.S. Mortgage Insurance segment increased $4 million primarily attributable to higher operating costs driven mostly by increased sales in the current year. |
• | Our U.S. Life Insurance segment increased $21 million driven mostly by our life insurance business principally from higher lapses primarily associated with our large 20-year term life insurance block entering its post-level premium period, partially offset by a $10 million unfavorable model correction in our universal life insurance products in the prior year that did not recur. Our fixed annuities business increased $5 million largely related to higher DAC amortization reflecting lower net spreads and the impact of unfavorable market changes in the current year. |
• | Our Runoff segment increased $15 million mainly related to higher DAC amortization in our variable annuity products principally from unfavorable equity market performance in the current year. |
Three months ended |
||||||||
March 31, |
||||||||
(Amounts in millions) |
2020 |
2019 |
||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | (66 |
) | $ | 174 |
|||
Less: net income (loss) from continuing operations attributable to noncontrolling interests |
(6 |
) | 20 |
|||||
Less: net income from discontinued operations attributable to noncontrolling interests |
— |
36 |
||||||
Net income (loss) |
(72 |
) | 230 |
|||||
Less: income from discontinued operations, net of taxes |
— |
62 |
||||||
Income (loss) from continuing operations |
(72 |
) | 168 |
|||||
Less: net income (loss) from continuing operations attributable to noncontrolling interests |
(6 |
) | 20 |
|||||
Income (loss) from continuing operations available to Genworth Financial, Inc.’s |
(66 |
) | 148 |
|||||
Adjustments to income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders: |
||||||||
Net investment (gains) losses, net (1) |
115 |
(71 |
) | |||||
Losses on early extinguishment of debt |
12 |
— |
||||||
Expenses related to restructuring |
1 |
4 |
||||||
Taxes on adjustments |
(29 |
) | 14 |
|||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | 33 |
$ | 95 |
||||
(1) |
For the three months ended March 31, 2020 and 2019, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $(11) million and $(2) million, respectively, and adjusted for net investment gains (losses) attributable to noncontrolling interests of $(26) million and $6 million, respectively. |
Three months ended |
||||||||
March 31, |
||||||||
(Amounts in millions, except per share amounts) |
2020 |
2019 |
||||||
Income (loss) from continuing operations available to Genworth Financial, |
||||||||
Basic |
$ | (0.13 |
) | $ | 0.29 |
|||
Diluted |
$ | (0.13 |
) | $ | 0.29 |
|||
Net income (loss) available to Genworth Financial, Inc.’s common |
||||||||
Basic |
$ | (0.13 |
) | $ | 0.35 |
|||
Diluted |
$ | (0.13 |
) | $ | 0.34 |
|||
Adjusted operating income available to Genworth Financial, Inc.’scommon stockholders per share: |
||||||||
Basic |
$ | 0.07 |
$ | 0.19 |
||||
Diluted |
$ | 0.07 |
$ | 0.19 |
||||
Weighted-average common shares outstanding: |
||||||||
Basic |
504.3 |
501.2 |
||||||
Diluted (1) |
504.3 |
508.6 |
||||||
(1) |
Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.’s common stockholders for the three months ended March 31, 2020, we were required to use basic weighted-average common shares outstanding as the inclusion of shares for stock options, restricted stock units and stock appreciation rights of 5.4 million would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.’s common stockholders for the three months ended March 31, 2020, dilutive potential weighted-average common shares outstanding would have been 509.7 million. |
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2020 |
2019 |
2020 vs. 2019 |
|||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | 226 |
$ | 194 |
$ | 32 |
16 |
% | ||||||||
Net investment income |
33 |
28 |
5 |
18 |
% | |||||||||||
Net investment gains (losses) |
— |
— |
— |
— |
% | |||||||||||
Policy fees and other income |
2 |
1 |
1 |
100 |
% | |||||||||||
Total revenues |
261 |
223 |
38 |
17 |
% | |||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
19 |
16 |
3 |
19 |
% | |||||||||||
Acquisition and operating expenses, net of deferrals |
50 |
46 |
4 |
9 |
% | |||||||||||
Amortization of deferred acquisition costs and intangibles |
4 |
4 |
— |
— |
% | |||||||||||
Total benefits and expenses |
73 |
66 |
7 |
11 |
% | |||||||||||
Income from continuing operations before income taxes |
188 |
157 |
31 |
20 |
% | |||||||||||
Provision for income taxes |
40 |
33 |
7 |
21 |
% | |||||||||||
Income from continuing operations |
148 |
124 |
24 |
19 |
% | |||||||||||
Adjustments to income from continuing operations: |
||||||||||||||||
Net investment (gains) losses |
— |
— |
— |
— |
% | |||||||||||
Taxes on adjustments |
— |
— |
— |
— |
% | |||||||||||
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders |
$ | 148 |
$ | 124 |
$ | 24 |
19 |
% | ||||||||
As of or for the three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2020 |
2019 |
2020 vs. 2019 |
|||||||||||||
Primary insurance in-force (1) |
$ | 198,500 |
$ | 170,400 |
$ | 28,100 |
16 |
% | ||||||||
Risk in-force |
$ | 47,900 |
$ | 41,300 |
$ | 6,600 |
16 |
% | ||||||||
New insurance written |
$ | 17,900 |
$ | 9,600 |
$ | 8,300 |
86 |
% | ||||||||
Net premiums written |
$ | 208 |
$ | 193 |
$ | 15 |
8 |
% |
(1) |
Primary insurance in-force represents the aggregate original loan balance for outstanding insurance policies and is used to determine premiums. Original loan balances are presented for policies with level renewal premiums. Amortized loan balances are presented for policies with annual, amortizing renewal premiums. |
Three months ended March 31, |
Increase (decrease) |
|||||||||||
2020 |
2019 |
2020 vs. 2019 |
||||||||||
Loss ratio |
8 |
% | 8 |
% | — |
% | ||||||
Expense ratio (net earned premiums) |
24 |
% | 25 |
% | (1 |
)% | ||||||
Expense ratio (net premiums written) |
26 |
% | 26 |
% | — |
% |
March 31, 2020 |
December 31, 2019 |
March 31, 2019 |
||||||||||
Primary insurance: |
||||||||||||
Insured loans in-force |
876,912 |
860,214 |
792,800 |
|||||||||
Delinquent loans |
15,648 |
16,607 |
16,206 |
|||||||||
Percentage of delinquent loans (delinquency rate) |
1.78 |
% | 1.93 |
% | 2.04 |
% | ||||||
Flow loans in-force |
866,562 |
849,472 |
780,733 |
|||||||||
Flow delinquent loans |
15,246 |
16,209 |
15,764 |
|||||||||
Percentage of flow delinquent loans (delinquency rate) |
1.76 |
% | 1.91 |
% | 2.02 |
% | ||||||
Bulk loans in-force |
10,350 |
10,742 |
12,067 |
|||||||||
Bulk delinquent loans (1) |
402 |
398 |
442 |
|||||||||
Percentage of bulk delinquent loans (delinquency rate) |
3.88 |
% | 3.71 |
% | 3.66 |
% | ||||||
A minus and sub-prime loans in-force |
12,243 |
12,792 |
14,712 |
|||||||||
A minus and sub-prime delinquent loans |
2,077 |
2,283 |
2,530 |
|||||||||
Percentage of A minus and sub-prime delinquent loans (delinquency rate) |
16.96 |
% | 17.85 |
% | 17.20 |
% | ||||||
Pool insurance: |
||||||||||||
Insured loans in-force |
4,071 |
4,122 |
4,470 |
|||||||||
Delinquent loans |
132 |
167 |
187 |
|||||||||
Percentage of delinquent loans (delinquency rate) |
3.24 |
% | 4.05 |
% | 4.18 |
% |
(1) |
Included loans where we were in a secondary loss position for which no reserve was established due to an existing deductible. Excluding these loans, bulk delinquent loans were 345 as of March 31, 2020, 348 as of December 31, 2019 and 360 as of March 31, 2019. |
March 31, 2020 |
||||||||||||||||
(Dollar amounts in millions) |
Delinquencies |
Direct case reserves (1) |
Risk in-force |
Reserves as % of risk in-force |
||||||||||||
Payments in default: |
||||||||||||||||
3 payments or less |
7,572 |
$ | 24 |
$ | 351 |
7 |
% | |||||||||
4 - 11 payments |
4,872 |
82 |
230 |
36 |
% | |||||||||||
12 payments or more |
2,802 |
95 |
142 |
67 |
% | |||||||||||
Total |
15,246 |
$ | 201 |
$ | 723 |
28 |
% | |||||||||
December 31, 2019 |
||||||||||||||||
(Dollar amounts in millions) |
Delinquencies |
Direct case reserves (1) |
Risk in-force |
Reserves as % of risk in-force |
||||||||||||
Payments in default: |
||||||||||||||||
3 payments or less |
8,524 |
$ | 27 |
$ | 386 |
7 |
% | |||||||||
4 - 11 payments |
4,836 |
78 |
224 |
35 |
% | |||||||||||
12 payments or more |
2,849 |
99 |
145 |
68 |
% | |||||||||||
Total |
16,209 |
$ | 204 |
$ | 755 |
27 |
% | |||||||||
(1) |
Direct flow case reserves exclude loss adjustment expenses, incurred but not reported and reinsurance reserves. |
Percent of primary risk in-force as ofMarch 31, 2020 |
Percent of total reserves as of March 31, 2020 (1) |
Delinquency rate |
||||||||||||||||||
March 31, 2020 |
December 31, 2019 |
March 31, 2019 |
||||||||||||||||||
By Region: |
||||||||||||||||||||
Southeast (2) |
19 |
% | 20 |
% | 2.00 |
% | 2.15 |
% | 2.39 |
% | ||||||||||
Pacific (3) |
18 |
12 |
1.29 |
% | 1.36 |
% | 1.29 |
% | ||||||||||||
South Central (4) |
17 |
12 |
1.68 |
% | 1.84 |
% | 1.97 |
% | ||||||||||||
Northeast (5) |
12 |
26 |
2.50 |
% | 2.72 |
% | 3.10 |
% | ||||||||||||
North Central (6) |
10 |
10 |
1.82 |
% | 1.91 |
% | 1.90 |
% | ||||||||||||
Great Lakes (7) |
10 |
7 |
1.53 |
% | 1.69 |
% | 1.62 |
% | ||||||||||||
Mid-Atlantic (8) |
6 |
5 |
1.72 |
% | 1.90 |
% | 2.11 |
% | ||||||||||||
New England (9) |
5 |
6 |
1.80 |
% | 1.92 |
% | 2.05 |
% | ||||||||||||
Plains (10) |
3 |
2 |
1.50 |
% | 1.69 |
% | 1.82 |
% | ||||||||||||
Total |
100 |
% | 100 |
% | 1.78 |
% | 1.93 |
% | 2.04 |
% | ||||||||||
(1) |
Total reserves were $230 million as of March 31, 2020. |
(2) |
Alabama, Arkansas, Florida, Georgia, Mississippi, North Carolina, South Carolina and Tennessee. |
(3) |
Alaska, California, Hawaii, Nevada, Oregon and Washington. |
(4) |
Arizona, Colorado, Louisiana, New Mexico, Oklahoma, Texas and Utah. |
(5) |
New Jersey, New York and Pennsylvania. |
(6) |
Illinois, Minnesota, Missouri and Wisconsin. |
(7) |
Indiana, Kentucky, Michigan and Ohio. |
(8) |
Delaware, Maryland, Virginia, Washington D.C. and West Virginia. |
(9) |
Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island and Vermont. |
(10) |
Idaho, Iowa, Kansas, Montana, Nebraska, North Dakota, South Dakota and Wyoming. |
Percent of primary risk in-force as ofMarch 31, 2020 |
Percent of total reserves as of March 31, 2020 (1) |
Delinquency rate |
||||||||||||||||||
March 31, 2020 |
December 31, 2019 |
March 31, 2019 |
||||||||||||||||||
By State: |
||||||||||||||||||||
California |
11 |
% | 7 |
% | 1.33 |
% | 1.42 |
% | 1.27 |
% | ||||||||||
Texas |
7 |
% | 5 |
% | 1.83 |
% | 2.02 |
% | 2.03 |
% | ||||||||||
Florida |
6 |
% | 10 |
% | 1.97 |
% | 2.13 |
% | 2.61 |
% | ||||||||||
New York |
5 |
% | 15 |
% | 2.71 |
% | 3.00 |
% | 3.42 |
% | ||||||||||
Illinois |
5 |
% | 6 |
% | 2.15 |
% | 2.27 |
% | 2.23 |
% | ||||||||||
Washington |
4 |
% | 2 |
% | 1.09 |
% | 1.10 |
% | 1.05 |
% | ||||||||||
Michigan |
4 |
% | 2 |
% | 1.32 |
% | 1.44 |
% | 1.30 |
% | ||||||||||
Pennsylvania |
4 |
% | 4 |
% | 1.98 |
% | 2.15 |
% | 2.37 |
% | ||||||||||
North Carolina |
4 |
% | 2 |
% | 1.65 |
% | 1.79 |
% | 1.96 |
% | ||||||||||
Ohio |
3 |
% | 3 |
% | 1.62 |
% | 1.84 |
% | 1.82 |
% |
(1) |
Total reserves were $230 million as of March 31, 2020. |
(Amounts in millions) |
Average rate |
Percent of total reserves (1) |
Primary insurance in-force |
Percent of total |
Primary risk in-force |
Percent of total |
||||||||||||||||||
Policy Year |
||||||||||||||||||||||||
2004 and prior |
6.14 |
% | 7.2 |
% |
$ | 1,290 |
0.6 |
% | $ | 242 |
0.5 |
% | ||||||||||||
2005 to 2008 |
5.47 |
% | 48.2 |
14,870 |
7.5 |
3,400 |
7.1 |
|||||||||||||||||
2009 to 2013 |
4.22 |
% | 4.0 |
6,246 |
3.1 |
1,465 |
3.1 |
|||||||||||||||||
2014 |
4.46 |
% | 4.0 |
6,492 |
3.3 |
1,561 |
3.3 |
|||||||||||||||||
2015 |
4.16 |
% | 5.9 |
13,408 |
6.8 |
3,227 |
6.7 |
|||||||||||||||||
2016 |
3.89 |
% | 8.7 |
25,079 |
12.6 |
6,031 |
12.6 |
|||||||||||||||||
2017 |
4.25 |
% | 9.6 |
27,335 |
13.8 |
6,616 |
13.8 |
|||||||||||||||||
2018 |
4.76 |
% | 9.1 |
29,005 |
14.6 |
7,034 |
14.7 |
|||||||||||||||||
2019 |
4.26 |
% | 3.3 |
56,918 |
28.7 |
13,912 |
29.1 |
|||||||||||||||||
2020 |
3.82 |
% | — |
17,824 |
9.0 |
4,378 |
9.1 |
|||||||||||||||||
Total portfolio |
4.40 |
% | 100.0 |
% | $ | 198,467 |
100.0 |
% | $ | 47,866 |
100.0 |
% | ||||||||||||
(1) |
Total reserves were $230 million as of March 31, 2020. |
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2020 |
2019 |
2020 vs. 2019 |
|||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | 69 |
$ | 83 |
$ | (14 |
) | (17 |
)% | |||||||
Net investment income |
10 |
16 |
(6 |
) | (38 |
)% | ||||||||||
Net investment gains (losses) |
(53 |
) | 12 |
(65 |
) | NM |
(1) | |||||||||
Policy fees and other income |
1 |
(1 |
) | 2 |
200 |
% | ||||||||||
Total revenues |
27 |
110 |
(83 |
) | (75 |
)% | ||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
24 |
28 |
(4 |
) | (14 |
)% | ||||||||||
Acquisition and operating expenses, net of deferrals |
17 |
17 |
— |
— |
% | |||||||||||
Amortization of deferred acquisition costs and intangibles |
8 |
9 |
(1 |
) | (11 |
)% | ||||||||||
Interest expense |
1 |
2 |
(1 |
) | (50 |
)% | ||||||||||
Total benefits and expenses |
50 |
56 |
(6 |
) | (11 |
)% | ||||||||||
Income (loss) from continuing operations before income taxes |
(23 |
) | 54 |
(77 |
) | (143 |
)% | |||||||||
Provision (benefit) for income taxes |
(7 |
) | 16 |
(23 |
) | (144 |
)% | |||||||||
Income (loss) from continuing operations |
(16 |
) | 38 |
(54 |
) | (142 |
)% | |||||||||
Less: net income (loss) from continuing operations attributable to noncontrolling |
(6 |
) | 20 |
(26 |
) | (130 |
)% | |||||||||
Income (loss) from continuing operations available to Genworth Financial, Inc.’s |
(10 |
) | 18 |
(28 |
) | (156 |
)% | |||||||||
Adjustments to income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||
Net investment (gains) losses, net (2) |
27 |
(6 |
) | 33 |
NM |
(1) | ||||||||||
Taxes on adjustments |
(8 |
) | 2 |
(10 |
) | NM |
(1) | |||||||||
Adjusted operating income available to Genworth Financial, Inc.’scommon stockholders |
$ | 9 |
$ | 14 |
$ | (5 |
) | (36 |
)% | |||||||
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
(2) |
For the three months ended March 31, 2020 and 2019, net investment (gains) losses were adjusted for the portion of net investment gains (losses) attributable to noncontrolling interests of $(26) million and $6 million, respectively. |
As of or for the three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2020 |
2019 |
2020 vs. 2019 |
|||||||||||||
Primary insurance in-force |
$ | 188,400 |
$ | 219,200 |
$ | (30,800 |
) | (14 |
)% | |||||||
Risk in-force |
$ | 65,700 |
$ | 76,300 |
$ | (10,600 |
) | (14 |
)% | |||||||
New insurance written |
$ | 4,300 |
$ | 3,900 |
$ | 400 |
10 |
% | ||||||||
Net premiums written |
$ | 62 |
$ | 52 |
$ | 10 |
19 |
% |
Three months ended March 31, |
Increase (decrease) |
|||||||||||
2020 |
2019 |
2020 vs. 2019 |
||||||||||
Loss ratio |
34 |
% | 34 |
% | — |
% | ||||||
Expense ratio (net earned premiums) |
36 |
% | 31 |
% | 5 |
% | ||||||
Expense ratio (net premiums written) |
40 |
% | 50 |
% | (10 |
)% |
March 31, 2020 |
December 31, 2019 |
March 31, 2019 |
||||||||||
Primary insured loans in-force |
1,284,120 |
1,290,216 |
1,323,172 |
|||||||||
Delinquent loans |
7,274 |
7,221 |
7,490 |
|||||||||
Percentage of delinquent loans (delinquency rate) |
0.57 |
% | 0.56 |
% | 0.57 |
% | ||||||
Flow loans in-force |
1,183,889 |
1,189,019 |
1,217,050 |
|||||||||
Flow delinquent loans |
7,055 |
7,003 |
7,265 |
|||||||||
Percentage of flow delinquent loans (delinquency rate) |
0.60 |
% | 0.59 |
% | 0.60 |
% | ||||||
Bulk loans in-force |
100,231 |
101,197 |
106,122 |
|||||||||
Bulk delinquent loans |
219 |
218 |
225 |
|||||||||
Percentage of bulk delinquent loans (delinquency rate) |
0.22 |
% | 0.22 |
% | 0.21 |
% |
Percent of primary risk in-force as ofMarch 31, 2020 |
Delinquency rate |
|||||||||||||||
March 31, 2020 |
December 31, 2019 |
March 31, 2019 |
||||||||||||||
By state and territory: |
||||||||||||||||
New South Wales |
27 |
% | 0.44 |
% | 0.42 |
% | 0.41 |
% | ||||||||
Queensland |
23 |
0.75 |
% | 0.75 |
% | 0.74 |
% | |||||||||
Victoria |
23 |
0.42 |
% | 0.41 |
% | 0.42 |
% | |||||||||
Western Australia |
13 |
1.00 |
% | 1.00 |
% | 1.05 |
% | |||||||||
South Australia |
6 |
0.67 |
% | 0.65 |
% | 0.69 |
% | |||||||||
Australian Capital Territory |
3 |
0.25 |
% | 0.24 |
% | 0.19 |
% | |||||||||
Tasmania |
2 |
0.30 |
% | 0.29 |
% | 0.28 |
% | |||||||||
New Zealand |
2 |
0.02 |
% | 0.02 |
% | 0.04 |
% | |||||||||
Northern Territory |
1 |
0.83 |
% | 0.71 |
% | 0.76 |
% | |||||||||
Total |
100 |
% | 0.57 |
% | 0.56 |
% | 0.57 |
% | ||||||||
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2020 |
2019 |
2020 vs. 2019 |
|||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | 718 |
$ | 709 |
$ | 9 |
1 |
% | ||||||||
Net investment income |
695 |
701 |
(6 |
) | (1 |
)% | ||||||||||
Net investment gains (losses) |
(70 |
) | 84 |
(154 |
) | (183 |
)% | |||||||||
Policy fees and other income |
144 |
151 |
(7 |
) | (5 |
)% | ||||||||||
Total revenues |
1,487 |
1,645 |
(158 |
) | (10 |
)% | ||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
1,297 |
1,236 |
61 |
5 |
% | |||||||||||
Interest credited |
100 |
106 |
(6 |
) | (6 |
)% | ||||||||||
Acquisition and operating expenses, net of deferrals |
151 |
148 |
3 |
2 |
% | |||||||||||
Amortization of deferred acquisition costs and intangibles |
87 |
66 |
21 |
32 |
% | |||||||||||
Interest expense |
5 |
5 |
— |
— |
% | |||||||||||
Total benefits and expenses |
1,640 |
1,561 |
79 |
5 |
% | |||||||||||
Income (loss) from continuing operations before income taxes |
(153 |
) | 84 |
(237 |
) | NM |
(1) | |||||||||
Provision (benefit) for income taxes |
(27 |
) | 24 |
(51 |
) | NM |
(1) | |||||||||
Income (loss) from continuing operations |
(126 |
) | 60 |
(186 |
) | NM |
(1) | |||||||||
Adjustments to income (loss) from continuing operations: |
||||||||||||||||
Net investment (gains) losses, net (2) |
67 |
(86 |
) | 153 |
178 |
% | ||||||||||
Losses on early extinguishment of debt |
4 |
— |
4 |
NM |
(1) | |||||||||||
Expenses related to restructuring |
— |
4 |
(4 |
) | (100 |
)% | ||||||||||
Taxes on adjustments |
(15 |
) | 17 |
(32 |
) | (188 |
)% | |||||||||
Adjusted operating loss available to Genworth Financial, Inc.’s |
$ | (70 |
) | $ | (5 |
) | $ | (65 |
) | NM |
(1) | |||||
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
(2) |
For the three months ended March 31, 2020 and 2019, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $(3) million and $(2) million, respectively. |
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2020 |
2019 |
2020 vs. 2019 |
|||||||||||||
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||
Long-term care insurance |
$ | 1 |
$ | (20 |
) | $ | 21 |
105 |
% | |||||||
Life insurance |
(77 |
) | (2 |
) | (75 |
) | NM |
(1) | ||||||||
Fixed annuities |
6 |
17 |
(11 |
) | (65 |
)% | ||||||||||
Total adjusted operating loss available to Genworth Financial, Inc.’s common stockholders |
$ | (70 |
) | $ | (5 |
) | $ | (65 |
) | NM |
(1) | |||||
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
• | Our long-term care insurance business had adjusted operating income available to Genworth Financial, Inc.’s common stockholders of $1 million in the current year compared to an adjusted operating loss available to Genworth Financial, Inc.’s common stockholders of $20 million in the prior year. The increase to income in the current year from a loss in the prior year was primarily from $52 million of higher premiums and reduced benefits in the current year from in-force rate actions approved and implemented, a slightly favorable impact from benefit utilization rate updates in the current year compared to an unfavorable impact in the prior year and continued favorable development on prior year incurred but not reported claims. These increases were partially offset by higher frequency and severity of new claims in the current year. |
• | The adjusted operating loss available to Genworth Financial, Inc.’s common stockholders for our life insurance business increased $75 million mainly attributable to higher lapses primarily associated with our large 20-year term life insurance block entering its post-level premium period, higher reserves in our 10-year term universal life insurance block entering its post-level premium period during the premium grace period and from higher mortality in our universal and term life insurance products in the current year compared to the prior year. |
• | Adjusted operating income available to Genworth Financial, Inc.’s common stockholders decreased $11 million in our fixed annuities business predominantly from higher reserves and DAC amortization in our fixed indexed annuities driven by unfavorable market changes in the current year, lower mortality in our single premium immediate annuities and a decrease in net spreads due to the runoff of the block. These decreases were partially offset by $13 million of unfavorable charges in connection with loss recognition testing in our fixed immediate annuity products in the prior year that did not recur. |
• | Our long-term care insurance business increased $14 million largely from $34 million of increased premiums in the current year from in-force rate actions approved and implemented, partially offset by policy terminations and policies entering paid-up status in the current year. |
• | Our life insurance business decreased $5 million mainly attributable to the continued runoff of our term life insurance products in the current year. |
• | Our long-term care insurance business increased $13 million largely from higher average invested assets, higher income on U.S. government treasury inflation protected securities and an increase in bond calls, partially offset by lower gains from limited partnerships in the current year. |
• | Our life insurance business decreased $3 million principally related to lower gains from limited partnerships in the current year. |
• | Our fixed annuities business decreased $16 million largely attributable to lower average invested assets in the current year due to block runoff. |
• | Our long-term care insurance business had net investment losses of $55 million in the current year compared to net investment gains of $80 million in the prior year. The change to net investment losses in the current year from net investment gains in the prior year was mainly driven by unrealized losses from changes in the fair value of equity securities in the current year compared to unrealized gains in the prior year. The change was also attributable to net gains from the sale of investment securities in the prior year that did not recur. |
• | Net investment gains in our life insurance business decreased $9 million primarily related to lower net gains from the sale of investment securities in the current year. |
• | Net investment losses in our fixed annuities business increased $10 million primarily related to derivative losses in the current year compared to derivative gains in the prior year. The increase was partially offset by gains on embedded derivatives related to our fixed indexed annuity products in the current year compared to losses in the prior year. |
• | Our long-term care insurance business increased $1 million principally from the aging of the in-force block (including higher frequency of new claims), higher incremental reserves of $39 million recorded in connection with an accrual for profits followed by losses and higher severity of new claims in the current year. These increases were mostly offset by a higher favorable impact of $34 million from reduced benefits in the current year related to in-force rate actions approved and implemented, a slightly favorable impact from benefit utilization rate updates in the current year compared to an unfavorable impact in the prior year and favorable development on prior year incurred but not reported claims. |
• | Our life insurance business increased $60 million primarily attributable to higher reserves in our 10-year term universal life insurance block entering its post-level premium period during the premium grace period and from higher mortality in our universal and term life insurance products in the current year compared to the prior year. |
• | Our fixed annuities business was flat as higher reserves in our fixed indexed annuities driven by unfavorable market changes in the current year and lower mortality in our single premium immediate annuities were offset by $17 million of higher reserves recorded in the prior year related to loss recognition testing in our fixed immediate annuity products that did not recur. |
• | Our life insurance business increased $17 million principally from higher lapses primarily associated with our large 20-year term life insurance block entering its post-level premium period, partially offset by a $10 million unfavorable model correction in our universal life insurance products in the prior year that did not recur. |
• | Our fixed annuities business increased $5 million largely related to higher DAC amortization reflecting lower net spreads and the impact of unfavorable market changes in the current year. |
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2020 |
2019 |
2020 vs. 2019 |
|||||||||||||
Net earned premiums: |
||||||||||||||||
Individual long-term care insurance |
$ | 611 |
$ | 599 |
$ | 12 |
2 |
% | ||||||||
Group long-term care insurance |
31 |
29 |
2 |
7 |
% | |||||||||||
Total |
$ | 642 |
$ | 628 |
$ | 14 |
2 |
% | ||||||||
Loss ratio |
78 |
% | 81 |
% | (3 |
)% |
As of or for the three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2020 |
2019 |
2020 vs. 2019 |
|||||||||||||
Term and whole life insurance |
||||||||||||||||
Net earned premiums |
$ | 76 |
$ | 81 |
$ (5 |
) | (6 |
)% | ||||||||
Life insurance in-force, net of reinsurance |
75,992 |
95,245 |
(19,253 |
) | (20 |
)% | ||||||||||
Life insurance in-force before reinsurance |
389,553 |
427,879 |
(38,326 |
) | (9 |
)% | ||||||||||
Term universal life insurance |
||||||||||||||||
Net deposits |
$ | 56 |
$ | 58 |
$ | (2 |
) | (3 |
)% | |||||||
Life insurance in-force, net of reinsurance |
111,945 |
114,894 |
(2,949 |
) | (3 |
)% | ||||||||||
Life insurance in-force before reinsurance |
112,710 |
115,691 |
(2,981 |
) | (3 |
)% | ||||||||||
Universal life insurance |
||||||||||||||||
Net deposits |
$ | 71 |
$ | 76 |
$ | (5 |
) | (7 |
)% | |||||||
Life insurance in-force, net of reinsurance |
33,552 |
34,961 |
(1,409 |
) | (4 |
)% | ||||||||||
Life insurance in-force before reinsurance |
38,144 |
39,785 |
(1,641 |
) | (4 |
)% | ||||||||||
Total life insurance |
||||||||||||||||
Net earned premiums and deposits |
$ | 203 |
$ | 215 |
$ | (12 |
) | (6 |
)% | |||||||
Life insurance in-force, net of reinsurance |
221,489 |
245,100 |
(23,611 |
) | (10 |
)% | ||||||||||
Life insurance in-force before reinsurance |
540,407 |
583,355 |
(42,948 |
) | (7 |
)% |
As of or for the three months ended March 31, |
||||||||
(Amounts in millions) |
2020 |
2019 |
||||||
Account value, beginning of period |
$ | 13,023 |
$ | 14,348 |
||||
Deposits |
22 |
29 |
||||||
Surrenders, benefits and product charges |
(467 |
) | (516 |
) | ||||
Net flows |
(445 |
) | (487 |
) | ||||
Interest credited and investment performance |
61 |
142 |
||||||
Effect of accumulated net unrealized investment gains (losses) |
(152 |
) | 106 |
|||||
Account value, end of period |
$ | 12,487 |
$ | 14,109 |
||||
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2020 |
2019 |
2020 vs. 2019 |
|||||||||||||
Revenues: |
||||||||||||||||
Net investment income |
$ | 49 |
$ | 47 |
$ | 2 |
4 |
% | ||||||||
Net investment gains (losses) |
(75 |
) | — |
(75 |
) | NM |
(1) | |||||||||
Policy fees and other income |
33 |
35 |
(2 |
) | (6 |
)% | ||||||||||
Total revenues |
7 |
82 |
(75 |
) | (91 |
)% | ||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
20 |
1 |
19 |
NM |
(1) | |||||||||||
Interest credited |
41 |
41 |
— |
— |
% | |||||||||||
Acquisition and operating expenses, net of deferrals |
13 |
13 |
— |
— |
% | |||||||||||
Amortization of deferred acquisition costs and intangibles |
17 |
2 |
15 |
NM |
(1) | |||||||||||
Total benefits and expenses |
91 |
57 |
34 |
60 |
% | |||||||||||
Income (loss) from continuing operations before income taxes |
(84 |
) | 25 |
(109 |
) | NM |
(1) | |||||||||
Provision (benefit) for income taxes |
(18 |
) | 5 |
(23 |
) | NM |
(1) | |||||||||
Income (loss) from continuing operations |
(66 |
) | 20 |
(86 |
) | NM |
(1) | |||||||||
Adjustments to income (loss) from continuing operations: |
||||||||||||||||
Net investment (gains) losses, net (2) |
67 |
— |
67 |
NM |
(1) | |||||||||||
Taxes on adjustments |
(14 |
) | — |
(14 |
) | NM |
(1) | |||||||||
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | (13 |
) | $ | 20 |
$ | (33 |
) | (165 |
)% | ||||||
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
(2) |
For the three months ended March 31, 2020, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $(8) million. |
As of or for the three months ended March 31, |
||||||||
(Amounts in millions) |
2020 |
2019 |
||||||
Account value, beginning of period |
$ | 5,042 |
$ | 4,918 |
||||
Deposits |
4 |
7 |
||||||
Surrenders, benefits and product charges |
(166 |
) | (161 |
) | ||||
Net flows |
(162 |
) | (154 |
) | ||||
Interest credited and investment performance |
(359 |
) | 349 |
|||||
Account value, end of period |
$ | 4,521 |
$ | 5,113 |
||||
As of or for the three months ended March 31, |
||||||||
(Amounts in millions) |
2020 |
2019 |
||||||
Funding Agreements |
||||||||
Account value, beginning of period |
$ | 253 |
$ | 381 |
||||
Surrenders and benefits |
(1 |
) | (78 |
) | ||||
Net flows |
(1 |
) | (78 |
) | ||||
Interest credited |
1 |
2 |
||||||
Account value, end of period |
$ | 253 |
$ | 305 |
||||
Three months ended March 31, |
Increase (decrease) and percentage change |
|||||||||||||||
(Amounts in millions) |
2020 |
2019 |
2020 vs. 2019 |
|||||||||||||
Revenues: |
||||||||||||||||
Premiums |
$ | 2 |
$ | 2 |
$ | — |
— |
% | ||||||||
Net investment income |
6 |
2 |
4 |
200 |
% | |||||||||||
Net investment gains (losses) |
46 |
(21 |
) | 67 |
NM |
(1) | ||||||||||
Policy fees and other income |
1 |
1 |
— |
— |
% | |||||||||||
Total revenues |
55 |
(16 |
) | 71 |
NM |
(1) | ||||||||||
Benefits and expenses: |
||||||||||||||||
Benefits and other changes in policy reserves |
1 |
1 |
— |
— |
% | |||||||||||
Acquisition and operating expenses, net of deferrals |
18 |
13 |
5 |
38 |
% | |||||||||||
Interest expense |
46 |
53 |
(7 |
) | (13 |
)% | ||||||||||
Total benefits and expenses |
65 |
67 |
(2 |
) | (3 |
)% | ||||||||||
Loss from continuing operations before income taxes |
(10 |
) | (83 |
) | 73 |
88 |
% | |||||||||
Provision (benefit) for income taxes |
2 |
(9 |
) | 11 |
122 |
% | ||||||||||
Loss from continuing operations |
(12 |
) | (74 |
) | 62 |
84 |
% | |||||||||
Adjustments to loss from continuing operations: |
||||||||||||||||
Net investment (gains) losses |
(46 |
) | 21 |
(67 |
) | NM |
(1) | |||||||||
Losses on early extinguishment of debt |
8 |
— |
8 |
NM |
(1) | |||||||||||
Expenses related to restructuring |
1 |
— |
1 |
NM |
(1) | |||||||||||
Taxes on adjustments |
8 |
(5 |
) | 13 |
NM |
(1) | ||||||||||
Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders |
$ | (41 |
) | $ | (58 |
) | $ | 17 |
29 |
% | ||||||
(1) |
We define “NM” as not meaningful for increases or decreases greater than 200%. |
Three months ended March 31, |
Increase (decrease) |
|||||||||||||||||||||||
2020 |
2019 |
2020 vs. 2019 |
||||||||||||||||||||||
(Amounts in millions) |
Yield |
Amount |
Yield |
Amount |
Yield |
Amount |
||||||||||||||||||
Fixed maturity securities—taxable |
4.6 |
% | $ | 622 |
4.6 |
% | $ | 613 |
— |
% | $ | 9 |
||||||||||||
Fixed maturity securities—non-taxable |
5.2 |
% | 2 |
6.1 |
% | 2 |
(0.9 |
)% | — |
|||||||||||||||
Equity securities |
3.8 |
% | 2 |
6.1 |
% | 4 |
(2.3 |
)% | (2 |
) | ||||||||||||||
Commercial mortgage loans |
4.9 |
% | 85 |
4.8 |
% | 82 |
0.1 |
% | 3 |
|||||||||||||||
Policy loans |
9.5 |
% | 49 |
9.5 |
% | 46 |
— |
% | 3 |
|||||||||||||||
Other invested assets (1) |
17.7 |
% | 47 |
33.5 |
% | 59 |
(15.8 |
)% | (12 |
) | ||||||||||||||
Cash, cash equivalents, restricted cash and short-term |
1.4 |
% | 11 |
2.1 |
% | 11 |
(0.7 |
)% | — |
|||||||||||||||
Gross investment income before expenses and fees |
4.9 |
% | 818 |
5.0 |
% | 817 |
(0.1 |
)% | 1 |
|||||||||||||||
Expenses and fees |
(0.2 |
)% | (25 |
) | (0.2 |
)% | (23 |
) | — |
% | (2 |
) | ||||||||||||
Net investment income |
4.7 |
% | $ | 793 |
4.8 |
% | $ | 794 |
(0.1 |
)% | $ | (1 |
) | |||||||||||
Average invested assets and cash |
$ | 67,334 |
$ | 65,678 |
$ | 1,656 |
||||||||||||||||||
(1) |
Investment income for other invested assets includes amortization of terminated cash flow hedges, which have no corresponding book value within the yield calculation and includes limited partnership investments, which are primarily equity-based and do not have fixed returns by period. |
Three months ended March 31, |
||||||||
(Amounts in millions) |
2020 |
2019 |
||||||
Available-for-sale fixed maturity securities: |
||||||||
Realized gains |
$ | 14 |
$ | 79 |
||||
Realized losses |
(1 |
) | (21 |
) | ||||
Net realized gains (losses) on available-for-sale fixed maturity securities |
13 |
58 |
||||||
Impairments: |
||||||||
Total other-than-temporary impairments |
— |
— |
||||||
Portion of other-than-temporary impairments recognized in other |
— |
— |
||||||
Net other-than-temporary impairments |
— |
— |
||||||
Net change in allowance for credit losses on available-for-sale fixed maturity |
— |
— |
||||||
Net realized gains (losses) on equity securities sold |
— |
3 |
||||||
Net unrealized gains (losses) on equity securities still held |
(19 |
) | 12 |
|||||
Limited partnerships |
(40 |
) | 15 |
|||||
Commercial mortgage loans |
— |
(1 |
) | |||||
Derivative instruments |
(105 |
) | (12 |
) | ||||
Other |
(1 |
) | — |
|||||
Net investment gains (losses) |
$ | (152 |
) | $ | 75 |
|||
• | We recorded net gains related to the sale of fixed maturity securities of $13 million during the three months ended March 31, 2020 primarily driven by portfolio rebalancing and asset exposure management. We recorded net realized gains of $58 million during the three months ended March 31, 2019 primarily related to cash tenders from merger and acquisition activity. |
• | The change to net unrealized losses on equity securities and limited partnership investments during the three months ended March 31, 2020 from net unrealized gains during the three months ended March 31, 2019 was primarily from unfavorable equity market performance in the current year compared to favorable equity market performance in the prior year. |
• | We recorded net losses related to derivatives of $105 million during the three months ended March 31, 2020 primarily associated with hedging programs that support our runoff variable annuity products and losses from our foreign currency hedging programs that support our Australia Mortgage Insurance segment due to the decline in the Australian dollar, partially offset by gains from hedging programs used to protect statutory surplus from equity market fluctuations. |
March 31, 2020 |
December 31, 2019 |
|||||||||||||||
(Amounts in millions) |
Carrying value |
% of total |
Carrying value |
% of total |
||||||||||||
Fixed maturity securities, available-for-sale: |
||||||||||||||||
Public |
$ | 41,864 |
57 |
% | $ | 42,162 |
57 |
% | ||||||||
Private |
17,187 |
24 |
18,177 |
24 |
||||||||||||
Equity securities |
188 |
— |
239 |
— |
||||||||||||
Commercial mortgage loans, net |
6,915 |
10 |
6,963 |
9 |
||||||||||||
Policy loans |
2,052 |
3 |
2,058 |
3 |
||||||||||||
Other invested assets |
2,465 |
3 |
1,632 |
2 |
||||||||||||
Cash, cash equivalents and restricted cash |
2,483 |
3 |
3,341 |
5 |
||||||||||||
Total cash, cash equivalents, restricted cash and invested assets |
$ | 73,154 |
100 |
% | $ | 74,572 |
100 |
% | ||||||||
(Amounts in millions) |
Amortized cost or cost |
Gross unrealized gains |
Gross unrealized losses |
Allowance for credit losses |
Fair value |
|||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and |
$ | 4,041 |
$ | 1,730 |
$ | — |
$ | — |
$ | 5,771 |
||||||||||
State and political subdivisions |
2,495 |
374 |
(5 |
) | — |
2,864 |
||||||||||||||
Non-U.S. government |
1,118 |
92 |
(9 |
) | — |
1,201 |
||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
4,333 |
556 |
(22 |
) | — |
4,867 |
||||||||||||||
Energy |
2,426 |
51 |
(385 |
) | — |
2,092 |
||||||||||||||
Finance and insurance |
7,179 |
548 |
(104 |
) | — |
7,623 |
||||||||||||||
Consumer—non-cyclical |
5,006 |
725 |
(46 |
) | — |
5,685 |
||||||||||||||
Technology and communications |
3,000 |
312 |
(37 |
) | — |
3,275 |
||||||||||||||
Industrial |
1,304 |
72 |
(31 |
) | — |
1,345 |
||||||||||||||
Capital goods |
2,420 |
272 |
(28 |
) | — |
2,664 |
||||||||||||||
Consumer—cyclical |
1,628 |
134 |
(43 |
) | — |
1,719 |
||||||||||||||
Transportation |
1,344 |
152 |
(23 |
) | — |
1,473 |
||||||||||||||
Other |
295 |
40 |
(1 |
) | — |
334 |
||||||||||||||
Total U.S. corporate |
28,935 |
2,862 |
(720 |
) | — |
31,077 |
||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||
Utilities |
757 |
24 |
(16 |
) | — |
765 |
||||||||||||||
Energy |
1,158 |
42 |
(102 |
) | — |
1,098 |
||||||||||||||
Finance and insurance |
2,023 |
128 |
(40 |
) | — |
2,111 |
||||||||||||||
Consumer—non-cyclical |
639 |
43 |
(8 |
) | — |
674 |
||||||||||||||
Technology and communications |
1,021 |
96 |
(8 |
) | — |
1,109 |
||||||||||||||
Industrial |
877 |
63 |
(29 |
) | — |
911 |
||||||||||||||
Capital goods |
546 |
25 |
(10 |
) | — |
561 |
||||||||||||||
Consumer—cyclical |
362 |
12 |
(12 |
) | — |
362 |
||||||||||||||
Transportation |
554 |
62 |
(13 |
) | — |
603 |
||||||||||||||
Other |
1,475 |
155 |
(25 |
) | — |
1,605 |
||||||||||||||
Total non-U.S. corporate |
9,412 |
650 |
(263 |
) | — |
9,799 |
||||||||||||||
Residential mortgage-backed (1) |
2,032 |
258 |
(17 |
) | — |
2,273 |
||||||||||||||
Commercial mortgage-backed |
2,876 |
169 |
(64 |
) | — |
2,981 |
||||||||||||||
Other asset-backed |
3,227 |
12 |
(154 |
) | — |
3,085 |
||||||||||||||
Total available-for-sale fixed |
$ | 54,136 |
$ | 6,147 |
$ | (1,232 |
) | $ | — |
$ | 59,051 |
|||||||||
(1) |
Fair value included $8 million collateralized by Alt-A residential mortgage loans and $19 million collateralized by sub-prime residential mortgage loans. |
Gross unrealized gains |
Gross unrealized losses |
|||||||||||||||||||||||
(Amounts in millions) |
Amortized cost or cost |
Not other-than- temporarily impaired |
Other-than- temporarily impaired |
Not other-than- temporarily impaired |
Other-than- temporarily impaired |
Fair value |
||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||
U.S. government, agencies andgovernment-sponsored enterprises |
$ | 4,073 |
$ | 952 |
$ | — |
$ | — |
$ | — |
$ | 5,025 |
||||||||||||
State and political subdivisions |
2,394 |
355 |
— |
(2 |
) | — |
2,747 |
|||||||||||||||||
Non-U.S. government |
1,235 |
117 |
— |
(2 |
) | — |
1,350 |
|||||||||||||||||
U.S. corporate: |
||||||||||||||||||||||||
Utilities |
4,322 |
675 |
— |
— |
— |
4,997 |
||||||||||||||||||
Energy |
2,404 |
303 |
— |
(8 |
) | — |
2,699 |
|||||||||||||||||
Finance and insurance |
6,977 |
798 |
— |
(1 |
) | — |
7,774 |
|||||||||||||||||
Consumer—non-cyclical |
4,909 |
796 |
— |
(4 |
) | — |
5,701 |
|||||||||||||||||
Technology and communications |
2,883 |
363 |
— |
(1 |
) | — |
3,245 |
|||||||||||||||||
Industrial |
1,271 |
125 |
— |
— |
— |
1,396 |
||||||||||||||||||
Capital goods |
2,345 |
367 |
— |
(1 |
) | — |
2,711 |
|||||||||||||||||
Consumer—cyclical |
1,590 |
172 |
— |
(2 |
) | — |
1,760 |
|||||||||||||||||
Transportation |
1,320 |
187 |
— |
(1 |
) | — |
1,506 |
|||||||||||||||||
Other |
292 |
30 |
— |
— |
— |
322 |
||||||||||||||||||
Total U.S. corporate |
28,313 |
3,816 |
— |
(18 |
) | — |
32,111 |
|||||||||||||||||
Non-U.S. corporate: |
||||||||||||||||||||||||
Utilities |
779 |
50 |
— |
— |
— |
829 |
||||||||||||||||||
Energy |
1,140 |
179 |
— |
— |
— |
1,319 |
||||||||||||||||||
Finance and insurance |
2,087 |
232 |
— |
— |
— |
2,319 |
||||||||||||||||||
Consumer—non-cyclical |
631 |
55 |
— |
(2 |
) | — |
684 |
|||||||||||||||||
Technology and communications |
1,010 |
128 |
— |
— |
— |
1,138 |
||||||||||||||||||
Industrial |
896 |
92 |
— |
— |
— |
988 |
||||||||||||||||||
Capital goods |
565 |
40 |
— |
— |
— |
605 |
||||||||||||||||||
Consumer—cyclical |
373 |
24 |
— |
— |
— |
397 |
||||||||||||||||||
Transportation |
557 |
73 |
— |
(1 |
) | — |
629 |
|||||||||||||||||
Other |
1,431 |
188 |
— |
(2 |
) | — |
1,617 |
|||||||||||||||||
Total non-U.S. corporate |
9,469 |
1,061 |
— |
(5 |
) | — |
10,525 |
|||||||||||||||||
Residential mortgage-backed (1) |
2,057 |
199 |
15 |
(1 |
) | — |
2,270 |
|||||||||||||||||
Commercial mortgage-backed |
2,897 |
137 |
— |
(8 |
) | — |
3,026 |
|||||||||||||||||
Other asset-backed |
3,262 |
30 |
— |
(7 |
) | — |
3,285 |
|||||||||||||||||
Total available-for-sale fixed |
$ | 53,700 |
$ | 6,667 |
$ | 15 |
$ | (43 |
) | $ | — |
$ | 60,339 |
|||||||||||
(1) |
Fair value included $9 million collateralized by Alt-A residential mortgage loans and $24 million collateralized by sub-prime residential mortgage loans. |
March 31, 2020 |
||||||||||||||||||||
(Dollar amounts in millions) |
Total amortized cost |
Number of loans |
Debt-to-value (1) |
Delinquent principal balance |
Number of delinquent loans |
|||||||||||||||
Loan Year |
||||||||||||||||||||
2010 and prior |
$ | 1,138 |
398 |
36 |
% | $ | — |
— |
||||||||||||
2011 |
163 |
41 |
37 |
% | — |
— |
||||||||||||||
2012 |
405 |
74 |
41 |
% | — |
— |
||||||||||||||
2013 |
570 |
113 |
46 |
% | — |
— |
||||||||||||||
2014 |
703 |
128 |
50 |
% | — |
— |
||||||||||||||
2015 |
810 |
133 |
55 |
% | — |
— |
||||||||||||||
2016 |
507 |
92 |
58 |
% | — |
— |
||||||||||||||
2017 |
735 |
141 |
60 |
% | — |
— |
||||||||||||||
2018 |
1,003 |
164 |
66 |
% | — |
— |
||||||||||||||
2019 |
803 |
111 |
71 |
% | — |
— |
||||||||||||||
2020 |
107 |
18 |
69 |
% | — |
— |
||||||||||||||
Total |
$ | 6,944 |
1,413 |
54 |
% | $ | — |
— |
||||||||||||
(1) |
Represents weighted-average debt-to-value as of March 31, 2020. |
December 31, 2019 |
||||||||||||||||||||
(Dollar amounts in millions) |
Total recorded investment |
Number of loans |
Debt-to-value (1) |
Delinquent principal balance |
Number of delinquent loans |
|||||||||||||||
Loan Year |
||||||||||||||||||||
2010 and prior |
$ | 1,182 |
419 |
37 |
% | $ | — |
— |
||||||||||||
2011 |
168 |
42 |
38 |
% | — |
— |
||||||||||||||
2012 |
415 |
75 |
42 |
% | — |
— |
||||||||||||||
2013 |
579 |
114 |
47 |
% | — |
— |
||||||||||||||
2014 |
720 |
129 |
50 |
% | — |
— |
||||||||||||||
2015 |
833 |
136 |
56 |
% | — |
— |
||||||||||||||
2016 |
517 |
93 |
59 |
% | — |
— |
||||||||||||||
2017 |
740 |
141 |
61 |
% | — |
— |
||||||||||||||
2018 |
1,019 |
165 |
66 |
% | — |
— |
||||||||||||||
2019 |
807 |
111 |
71 |
% | — |
— |
||||||||||||||
Total |
$ | 6,980 |
1,425 |
54 |
% | $ | — |
— |
||||||||||||
(1) |
Represents weighted-average debt-to-value as of December 31, 2019. |
March 31, 2020 |
December 31, 2019 |
|||||||||||||||
(Amounts in millions) |
Carrying value |
% of total |
Carrying value |
% of total |
||||||||||||
Derivatives |
$ | 1,101 |
44 |
% | $ | 290 |
18 |
% | ||||||||
Limited partnerships |
671 |
27 |
634 |
39 |
||||||||||||
Bank loan investments |
409 |
17 |
383 |
23 |
||||||||||||
Short-term investments |
213 |
9 |
260 |
16 |
||||||||||||
Securities lending collateral |
58 |
2 |
51 |
3 |
||||||||||||
Other investments |
13 |
1 |
14 |
1 |
||||||||||||
Total other invested assets |
$ | 2,465 |
100 |
% | $ | 1,632 |
100 |
% | ||||||||
(Notional in millions) |
Measurement |
December 31, 2019 |
Additions |
Maturities/ terminations |
March 31, 2020 |
|||||||||||||||
Derivatives designated as hedges |
||||||||||||||||||||
Cash flow hedges: |
||||||||||||||||||||
Interest rate swaps |
Notional |
$ | 8,968 |
$ | 1,158 |
$ | (1,102 |
) | $ | 9,024 |
||||||||||
Foreign currency swaps |
Notional |
110 |
— |
— |
110 |
|||||||||||||||
Total cash flow hedges |
9,078 |
1,158 |
(1,102 |
) | 9,134 |
|||||||||||||||
Total derivatives designated as hedges |
9,078 |
1,158 |
(1,102 |
) | 9,134 |
|||||||||||||||
Derivatives not designated as hedges |
||||||||||||||||||||
Interest rate swaps |
Notional |
4,674 |
— |
— |
4,674 |
|||||||||||||||
Equity index options |
Notional |
2,451 |
509 |
(531 |
) | 2,429 |
||||||||||||||
Financial futures |
Notional |
1,182 |
1,651 |
(1,266 |
) | 1,567 |
||||||||||||||
Other foreign currency contracts |
Notional |
628 |
1,819 |
(1,308 |
) | 1,139 |
||||||||||||||
Total derivatives not designated as hedges |
8,935 |
3,979 |
(3,105 |
) | 9,809 |
|||||||||||||||
Total derivatives |
$ | 18,013 |
$ | 5,137 |
$ | (4,207 |
) | $ | 18,943 |
|||||||||||
(Number of policies) |
Measurement |
December 31, 2019 |
Additions |
Maturities/ terminations |
March 31, 2020 |
|||||||||||||||
Derivatives not designated as hedges |
||||||||||||||||||||
GMWB embedded derivatives |
Policies |
25,623 |
— |
(561 |
) | 25,062 |
||||||||||||||
Fixed index annuity embedded derivatives |
Policies |
15,441 |
— |
(317 |
) | 15,124 |
||||||||||||||
Indexed universal life embedded derivatives |
Policies |
884 |
— |
(18 |
) | 866 |
• | Cash, cash equivalents, restricted cash and invested assets decreased $1,418 million primarily from decreases of $1,288 million, $858 million, and $51 million in fixed maturity securities, cash, cash equivalents and restricted cash and equity securities, respectively. The decrease in fixed maturity securities was predominantly related to lower unrealized gains principally from credit spread widening, largely in our U.S. and non-U.S. corporate bond investments, partially offset by a decrease in interest rates favorably impacting our U.S. government bond investments and net purchases in the current year. The decrease in cash, cash equivalents and restricted cash was largely related to the early redemption of Genworth Holdings’ senior notes originally scheduled to mature in June 2020, the early repayment of Rivermont I’s non-recourse funding obligations originally due in 2050 and net purchases of fixed maturity securities in the current year. Equity securities decreased principally from unfavorable equity market performance driven in large part by COVID-19. These decreases were partially offset by an increase of $833 million in other invested assets primarily from lower interest rates increasing derivative assets in the current year. |
• | Deferred tax asset decreased $106 million primarily due to higher unrealized gains on derivatives, partially offset by lower unrealized gains on investments in the current year. |
• | Separate account assets decreased $1,141 million primarily due to unfavorable equity market performance and surrenders in the current year. |
• | Future policy benefits decreased $1,045 million primarily driven by shadow accounting adjustments associated with the recognition of lower unrealized gains. The shadow accounting adjustments decreased future policy benefits by approximately $1,110 million, mostly in our long-term care insurance business, with an offsetting amount recorded in other comprehensive income (loss). This decrease was partially offset by aging of our long-term care insurance in-force block and an increase in incremental reserves of $41 million recorded in connection with an accrual for profits followed by losses in the current year. |
• | Policyholder account balances increased $96 million largely attributable to our variable annuity business from unfavorable equity market performance, partially offset by surrenders and benefits in our fixed annuities business in the current year. |
• | Liability for policy and contract claims increased $174 million due principally to our long-term care insurance business primarily attributable to new claims, which includes higher new claims frequency as a result of the aging of the in-force block, as well as higher severity, partially offset by favorable development on prior year incurred but not reported claims in the current year. |
• | Unearned premiums decreased $171 million principally related to our Australia mortgage insurance business due primarily to changes in foreign exchange rates, as the U.S. dollar strengthened against the |
Australian dollar as compared to the December 31, 2019 balance sheet rate. The decrease was also attributable to earned premiums outpacing written premiums in our U.S. mortgage insurance business and from policy terminations and policies entering paid-up status in our long-term care insurance business. |
• | Non-recourse funding obligations decreased $311 million due to the early redemption of Rivermont I’s outstanding non-recourse funding obligations originally due in 2050. |
• | Long-term borrowings decreased $426 million mainly attributable to the early redemption of Genworth Holdings’ 7.70% senior notes originally scheduled to mature in June 2020. In addition, Genworth Holdings repurchased $14 million principal amount of its senior notes with 2021 maturity dates in March 2020. |
• | We reported a net loss available to Genworth Financial, Inc.’s common stockholders of $66 million for the three months ended March 31, 2020. We also adopted new accounting guidance on January 1, 2020 related to estimating expected credit losses that was applied on a modified retrospective basis, resulting in a $55 million decrease to retained earnings in the current year. |
• | Derivatives qualifying as hedges increased $753 million primarily from a decrease in interest rates, partially offset by a decrease in net unrealized gains of $316 million driven largely by credit spread widening, mostly in our U.S. and non-U.S. corporate bond investments in the current year. |
(Amounts in millions) |
2020 |
2019 |
||||||
Net cash from operating activities |
$ | 680 |
$ | 134 |
||||
Net cash from (used by) investing activities |
(551 |
) | 277 |
|||||
Net cash used by financing activities |
(957 |
) | (375 |
) | ||||
Net increase (decrease) in cash before foreign exchange effect |
$ | (828 |
) | $ | 36 |
|||
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Assets |
||||||||||||||||||||
Investments: |
||||||||||||||||||||
Fixed maturity securities available-for-sale, at fair value (amortized cost of $54,136 and allowance for credit losses of $—) |
$ | — |
$ | — |
$ | 59,051 |
$ | — |
$ | 59,051 |
||||||||||
Equity securities, at fair value |
— |
— |
188 |
— |
188 |
|||||||||||||||
Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $4) |
— |
— |
6,944 |
— |
6,944 |
|||||||||||||||
Less: Allowance for credit losses |
— |
— |
(29 |
) | — |
(29 |
) | |||||||||||||
Commercial mortgage loans, net |
— |
— |
6,915 |
— |
6,915 |
|||||||||||||||
Policy loans |
— |
— |
2,052 |
— |
2,052 |
|||||||||||||||
Other invested assets |
— |
61 |
2,404 |
— |
2,465 |
|||||||||||||||
Investments in subsidiaries |
14,352 |
15,436 |
— |
(29,788 |
) | — |
||||||||||||||
Total investments |
14,352 |
15,497 |
70,610 |
(29,788 |
) | 70,671 |
||||||||||||||
Cash, cash equivalents and restricted cash |
— |
525 |
1,958 |
— |
2,483 |
|||||||||||||||
Accrued investment income |
— |
— |
707 |
— |
707 |
|||||||||||||||
Deferred acquisition costs |
— |
— |
1,898 |
— |
1,898 |
|||||||||||||||
Intangible assets and goodwill |
— |
— |
263 |
— |
263 |
|||||||||||||||
Reinsurance recoverable |
— |
— |
17,122 |
— |
17,122 |
|||||||||||||||
Less: Allowance for credit losses |
— |
— |
(42 |
) | — |
(42 |
) | |||||||||||||
Reinsurance recoverable, net |
— |
— |
17,080 |
— |
17,080 |
|||||||||||||||
Other assets |
(2 |
) | 233 |
225 |
— |
456 |
||||||||||||||
Intercompany notes receivable |
104 |
189 |
— |
(293 |
) | — |
||||||||||||||
Deferred tax assets |
7 |
827 |
(515 |
) | — |
319 |
||||||||||||||
Separate account assets |
— |
— |
4,967 |
— |
4,967 |
|||||||||||||||
Total assets |
$ | 14,461 |
$ | 17,271 |
$ | 97,193 |
$ | (30,081 |
) | $ | 98,844 |
|||||||||
Liabilities and equity |
||||||||||||||||||||
Liabilities: |
||||||||||||||||||||
Future policy benefits |
$ | — |
$ | — |
$ | 39,339 |
$ | — |
$ | 39,339 |
||||||||||
Policyholder account balances |
— |
— |
22,313 |
— |
22,313 |
|||||||||||||||
Liability for policy and contract claims |
— |
— |
11,132 |
— |
11,132 |
|||||||||||||||
Unearned premiums |
— |
— |
1,722 |
— |
1,722 |
|||||||||||||||
Other liabilities |
12 |
96 |
1,578 |
— |
1,686 |
|||||||||||||||
Intercompany notes payable |
— |
105 |
188 |
(293 |
) | — |
||||||||||||||
Long-term borrowings |
— |
2,729 |
122 |
— |
2,851 |
|||||||||||||||
Separate account liabilities |
— |
— |
4,967 |
— |
4,967 |
|||||||||||||||
Total liabilities |
12 |
2,930 |
81,361 |
(293 |
) | 84,010 |
||||||||||||||
Equity: |
||||||||||||||||||||
Common stock |
1 |
— |
3 |
(3 |
) | 1 |
||||||||||||||
Additional paid-in capital |
11,993 |
12,761 |
18,431 |
(31,192 |
) | 11,993 |
||||||||||||||
Accumulated other comprehensive income (loss) |
3,815 |
3,815 |
3,908 |
(7,723 |
) | 3,815 |
||||||||||||||
Retained earnings |
1,340 |
(2,235 |
) | (7,195 |
) | 9,430 |
1,340 |
|||||||||||||
Treasury stock, at cost |
(2,700 |
) | — |
— |
— |
(2,700 |
) | |||||||||||||
Total Genworth Financial, Inc.’s stockholders’ equity |
14,449 |
14,341 |
15,147 |
(29,488 |
) | 14,449 |
||||||||||||||
Noncontrolling interests |
— |
— |
685 |
(300 |
) | 385 |
||||||||||||||
Total equity |
14,449 |
14,341 |
15,832 |
(29,788 |
) | 14,834 |
||||||||||||||
Total liabilities and equity |
$ | 14,461 |
$ | 17,271 |
$ | 97,193 |
$ | (30,081 |
) | $ | 98,844 |
|||||||||
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Assets |
||||||||||||||||||||
Investments: |
||||||||||||||||||||
Fixed maturity securities available-for-sale, at fair value |
$ | — |
$ | — |
$ | 60,539 |
$ | (200 |
) | $ | 60,339 |
|||||||||
Equity securities, at fair value |
— |
— |
239 |
— |
239 |
|||||||||||||||
Commercial mortgage loans ($47 are restricted related to a securitization entity) |
— |
— |
6,963 |
— |
6,963 |
|||||||||||||||
Policy loans |
— |
— |
2,058 |
— |
2,058 |
|||||||||||||||
Other invested assets |
— |
71 |
1,561 |
— |
1,632 |
|||||||||||||||
Investments in subsidiaries |
14,079 |
15,090 |
— |
(29,169 |
) | — |
||||||||||||||
Total investments |
14,079 |
15,161 |
71,360 |
(29,369 |
) | 71,231 |
||||||||||||||
Cash, cash equivalents and restricted cash |
— |
1,461 |
1,880 |
— |
3,341 |
|||||||||||||||
Accrued investment income |
— |
— |
657 |
(3 |
) | 654 |
||||||||||||||
Deferred acquisition costs |
— |
— |
1,836 |
— |
1,836 |
|||||||||||||||
Intangible assets and goodwill |
— |
— |
201 |
— |
201 |
|||||||||||||||
Reinsurance recoverable |
— |
— |
17,103 |
— |
17,103 |
|||||||||||||||
Other assets |
4 |
48 |
392 |
(1 |
) | 443 |
||||||||||||||
Intercompany notes receivable |
119 |
132 |
— |
(251 |
) | — |
||||||||||||||
Deferred tax assets |
13 |
821 |
(409 |
) | — |
425 |
||||||||||||||
Separate account assets |
— |
— |
6,108 |
— |
6,108 |
|||||||||||||||
Total assets |
$ | 14,215 |
$ | 17,623 |
$ | 99,128 |
$ | (29,624 |
) | $ | 101,342 |
|||||||||
Liabilities and equity |
||||||||||||||||||||
Liabilities: |
||||||||||||||||||||
Future policy benefits |
$ | — |
$ | — |
$ | 40,384 |
$ | — |
$ | 40,384 |
||||||||||
Policyholder account balances |
— |
— |
22,217 |
— |
22,217 |
|||||||||||||||
Liability for policy and contract claims |
— |
— |
10,958 |
— |
10,958 |
|||||||||||||||
Unearned premiums |
— |
— |
1,893 |
— |
1,893 |
|||||||||||||||
Other liabilities |
30 |
99 |
1,438 |
(5 |
) | 1,562 |
||||||||||||||
Intercompany notes payable |
— |
319 |
132 |
(451 |
) | — |
||||||||||||||
Non-recourse funding obligations |
— |
— |
311 |
— |
311 |
|||||||||||||||
Long-term borrowings |
— |
3,137 |
140 |
— |
3,277 |
|||||||||||||||
Separate account liabilities |
— |
— |
6,108 |
— |
6,108 |
|||||||||||||||
Total liabilities |
30 |
3,555 |
83,581 |
(456 |
) | 86,710 |
||||||||||||||
Equity: |
||||||||||||||||||||
Common stock |
1 |
— |
3 |
(3 |
) | 1 |
||||||||||||||
Additional paid-in capital |
11,990 |
12,761 |
18,431 |
(31,192 |
) | 11,990 |
||||||||||||||
Accumulated other comprehensive income (loss) |
3,433 |
3,433 |
3,474 |
(6,907 |
) | 3,433 |
||||||||||||||
Retained earnings |
1,461 |
(2,126 |
) | (7,108 |
) | 9,234 |
1,461 |
|||||||||||||
Treasury stock, at cost |
(2,700 |
) | — |
— |
— |
(2,700 |
) | |||||||||||||
Total Genworth Financial, Inc.’s stockholders’ equity |
14,185 |
14,068 |
14,800 |
(28,868 |
) | 14,185 |
||||||||||||||
Noncontrolling interests |
— |
— |
747 |
(300 |
) | 447 |
||||||||||||||
Total equity |
14,185 |
14,068 |
15,547 |
(29,168 |
) | 14,632 |
||||||||||||||
Total liabilities and equity |
$ | 14,215 |
$ | 17,623 |
$ | 99,128 |
$ | (29,624 |
) | $ | 101,342 |
|||||||||
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Revenues: |
||||||||||||||||||||
Premiums |
$ | — |
$ | — |
$ | 1,015 |
$ | — |
$ | 1,015 |
||||||||||
Net investment income |
(1 |
) | 5 |
792 |
(3 |
) | 793 |
|||||||||||||
Net investment gains (losses) |
— |
10 |
(162 |
) | — |
(152 |
) | |||||||||||||
Policy fees and other income |
— |
1 |
182 |
(2 |
) | 181 |
||||||||||||||
Total revenues |
(1 |
) | 16 |
1,827 |
(5 |
) | 1,837 |
|||||||||||||
Benefits and expenses: |
||||||||||||||||||||
Benefits and other changes in policy reserves |
— |
— |
1,361 |
— |
1,361 |
|||||||||||||||
Interest credited |
— |
— |
141 |
— |
141 |
|||||||||||||||
Acquisition and operating expenses, net of deferrals |
8 |
10 |
231 |
— |
249 |
|||||||||||||||
Amortization of deferred acquisition costs and intangibles |
— |
— |
116 |
— |
116 |
|||||||||||||||
Interest expense |
— |
49 |
8 |
(5 |
) | 52 |
||||||||||||||
Total benefits and expenses |
8 |
59 |
1,857 |
(5 |
) | 1,919 |
||||||||||||||
Loss from continuing operations before income taxes and equity in loss of subsidiaries |
(9 |
) | (43 |
) | (30 |
) | — |
(82 |
) | |||||||||||
Provision (benefit) for income taxes |
3 |
(9 |
) | (4 |
) | — |
(10 |
) | ||||||||||||
Equity in loss of subsidiaries |
(54 |
) | (20 |
) | — |
74 |
— |
|||||||||||||
Loss from continuing operations |
(66 |
) | (54 |
) | (26 |
) | 74 |
(72 |
) | |||||||||||
Income from discontinued operations, net of taxes |
— |
— |
— |
— |
— |
|||||||||||||||
Net loss |
(66 |
) | (54 |
) | (26 |
) | 74 |
(72 |
) | |||||||||||
Less: net loss from continuing operations attributable to noncontrolling interests |
— |
— |
(6 |
) | — |
(6 |
) | |||||||||||||
Less: net income from discontinued operations attributable to noncontrolling interests |
— |
— |
— |
— |
— |
|||||||||||||||
Net loss available to Genworth Financial, Inc.’s common stockholders |
$ | (66 |
) | $ | (54 |
) | $ | (20 |
) | $ | 74 |
$ | (66 |
) | ||||||
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Revenues: |
||||||||||||||||||||
Premiums |
$ | — |
$ | — |
$ | 4,037 |
$ | — |
$ | 4,037 |
||||||||||
Net investment income |
(3 |
) | 10 |
3,228 |
(15 |
) | 3,220 |
|||||||||||||
Net investment gains (losses) |
— |
(5 |
) | 55 |
— |
50 |
||||||||||||||
Policy fees and other income |
— |
2 |
792 |
(5 |
) | 789 |
||||||||||||||
Total revenues |
(3 |
) | 7 |
8,112 |
(20 |
) | 8,096 |
|||||||||||||
Benefits and expenses: |
||||||||||||||||||||
Benefits and other changes in policy reserves |
— |
— |
5,163 |
— |
5,163 |
|||||||||||||||
Interest credited |
— |
— |
577 |
— |
577 |
|||||||||||||||
Acquisition and operating expenses, net of deferrals |
20 |
— |
942 |
— |
962 |
|||||||||||||||
Amortization of deferred acquisition costs and intangibles |
— |
— |
441 |
— |
441 |
|||||||||||||||
Interest expense |
3 |
231 |
25 |
(20 |
) | 239 |
||||||||||||||
Total benefits and expenses |
23 |
231 |
7,148 |
(20 |
) | 7,382 |
||||||||||||||
Income (loss) from continuing operations before income taxes and equity in income of subsidiaries |
(26 |
) | (224 |
) | 964 |
— |
714 |
|||||||||||||
Provision (benefit) for income taxes |
(3 |
) | (45 |
) | 243 |
— |
195 |
|||||||||||||
Equity in income of subsidiaries |
366 |
177 |
— |
(543 |
) | — |
||||||||||||||
Income (loss) from continuing operations |
343 |
(2 |
) | 721 |
(543 |
) | 519 |
|||||||||||||
Income (loss) from discontinued operations, net of taxes |
— |
(140 |
) | 151 |
— |
11 |
||||||||||||||
Net income (loss) |
343 |
(142 |
) | 872 |
(543 |
) | 530 |
|||||||||||||
Less: net income from continuing operations attributable to noncontrolling interests |
— |
— |
64 |
— |
64 |
|||||||||||||||
Less: net income from discontinued operations attributable to noncontrolling interests |
— |
— |
123 |
— |
123 |
|||||||||||||||
Net income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | 343 |
$ | (142 |
) | $ | 685 |
$ | (543 |
) | $ | 343 |
||||||||
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Net loss |
$ | (66 |
) | $ | (54 |
) | $ | (26 |
) | $ | 74 |
$ | (72 |
) | ||||||
Other comprehensive income (loss), net of taxes: |
||||||||||||||||||||
Net unrealized gains (losses) on securities without an allowance for credit losses |
(316 |
) | (316 |
) | (320 |
) | 632 |
(320 |
) | |||||||||||
Net unrealized gains (losses) on securities with an allowance for credit losses |
— |
— |
— |
— |
— |
|||||||||||||||
Derivatives qualifying as hedges |
753 |
753 |
803 |
(1,556 |
) | 753 |
||||||||||||||
Foreign currency translation and other adjustments |
(55 |
) | (55 |
) | (96 |
) | 108 |
(98 |
) | |||||||||||
Total other comprehensive income (loss) |
382 |
382 |
387 |
(816 |
) | 335 |
||||||||||||||
Total comprehensive income |
316 |
328 |
361 |
(742 |
) | 263 |
||||||||||||||
Less: comprehensive loss attributable to noncontrolling interests |
— |
— |
(53 |
) | — |
(53 |
) | |||||||||||||
Total comprehensive income available to Genworth Financial, Inc.’s common stockholders |
$ | 316 |
$ | 328 |
$ | 414 |
$ | (742 |
) | $ | 316 |
|||||||||
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Net income (loss) |
$ | 343 |
$ | (142 |
) | $ | 872 |
$ | (543 |
) | $ | 530 |
||||||||
Other comprehensive income (loss), net of taxes: |
||||||||||||||||||||
Net unrealized gains (losses) on securities not other-than-temporarily impaired |
859 |
842 |
846 |
(1,701 |
) | 846 |
||||||||||||||
Net unrealized gains (losses) on other-than-temporarily impaired securities |
2 |
2 |
2 |
(4 |
) | 2 |
||||||||||||||
Derivatives qualifying as hedges |
221 |
221 |
247 |
(468 |
) | 221 |
||||||||||||||
Foreign currency translation and other adjustments |
307 |
224 |
486 |
(530 |
) | 487 |
||||||||||||||
Total other comprehensive income (loss) |
1,389 |
1,289 |
1,581 |
(2,703 |
) | 1,556 |
||||||||||||||
Total comprehensive income |
1,732 |
1,147 |
2,453 |
(3,246 |
) | 2,086 |
||||||||||||||
Less: comprehensive income attributable to noncontrolling interests |
— |
— |
354 |
— |
354 |
|||||||||||||||
Total comprehensive income available to Genworth Financial, Inc.’s common stockholders |
$ | 1,732 |
$ | 1,147 |
$ | 2,099 |
$ | (3,246 |
) | $ | 1,732 |
|||||||||
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Cash flows from (used by) operating activities: |
||||||||||||||||||||
Net loss |
$ | (66 |
) | $ | (54 |
) | $ | (26 |
) | $ | 74 |
$ | (72 |
) | ||||||
Adjustments to reconcile net loss to net cash from (used by)operating activities: |
||||||||||||||||||||
Equity in loss from subsidiaries |
54 |
20 |
— |
(74 |
) | — |
||||||||||||||
Dividends from subsidiaries |
— |
11 |
(11 |
) | — |
— |
||||||||||||||
Amortization of fixed maturity securities discounts and premiums |
— |
2 |
(37 |
) | — |
(35 |
) | |||||||||||||
Net investment (gains) losses |
— |
(10 |
) | 162 |
— |
152 |
||||||||||||||
Charges assessed to policyholders |
— |
— |
(158 |
) | — |
(158 |
) | |||||||||||||
Acquisition costs deferred |
— |
— |
(4 |
) | — |
(4 |
) | |||||||||||||
Amortization of deferred acquisition costs and intangibles |
— |
— |
116 |
— |
116 |
|||||||||||||||
Deferred income taxes |
6 |
8 |
(25 |
) | — |
(11 |
) | |||||||||||||
Derivative instruments, limited partnerships and other |
— |
(63 |
) | 410 |
— |
347 |
||||||||||||||
Stock-based compensation expense |
10 |
— |
1 |
— |
11 |
|||||||||||||||
Change in certain assets and liabilities: |
||||||||||||||||||||
Accrued investment income and other assets |
7 |
(16 |
) | (93 |
) | (5 |
) | (107 |
) | |||||||||||
Insurance reserves |
— |
— |
328 |
— |
328 |
|||||||||||||||
Current tax liabilities |
(5 |
) | (16 |
) | 16 |
— |
(5 |
) | ||||||||||||
Other liabilities, policy and contract claims and otherpolicy-related balances |
(16 |
) | (147 |
) | 276 |
5 |
118 |
|||||||||||||
Net cash from (used by) operating activities |
(10 |
) | (265 |
) | 955 |
— |
680 |
|||||||||||||
Cash flows from (used by) investing activities: |
||||||||||||||||||||
Proceeds from maturities and repayments of investments: |
||||||||||||||||||||
Fixed maturity securities |
— |
— |
921 |
— |
921 |
|||||||||||||||
Commercial mortgage loans |
— |
— |
139 |
— |
139 |
|||||||||||||||
Other invested assets |
— |
— |
34 |
— |
34 |
|||||||||||||||
Proceeds from sales of investments: |
||||||||||||||||||||
Fixed maturity and equity securities |
— |
— |
369 |
— |
369 |
|||||||||||||||
Purchases and originations of investments: |
||||||||||||||||||||
Fixed maturity and equity securities |
— |
— |
(1,804 |
) | — |
(1,804 |
) | |||||||||||||
Commercial mortgage loans |
— |
— |
(107 |
) | — |
(107 |
) | |||||||||||||
Other invested assets |
— |
— |
(160 |
) | — |
(160 |
) | |||||||||||||
Short-term investments, net |
— |
20 |
28 |
— |
48 |
|||||||||||||||
Policy loans, net |
— |
— |
9 |
— |
9 |
|||||||||||||||
Intercompany notes receivable |
15 |
(57 |
) | 200 |
(158 |
) | — |
|||||||||||||
Capital contributions to subsidiaries |
(1 |
) | — |
1 |
— |
— |
||||||||||||||
Net cash from (used by) investing activities |
14 |
(37 |
) | (370 |
) | (158 |
) | (551 |
) | |||||||||||
Cash flows used by financing activities: |
||||||||||||||||||||
Deposits to universal life and investment contracts |
— |
— |
180 |
— |
180 |
|||||||||||||||
Withdrawals from universal life and investment contracts |
— |
— |
(493 |
) | — |
(493 |
) | |||||||||||||
Redemption of non-recourse funding obligations |
— |
— |
(315 |
) | — |
(315 |
) | |||||||||||||
Repayment and repurchase of long-term debt |
— |
(420 |
) | — |
— |
(420 |
) | |||||||||||||
Dividends paid to noncontrolling interests |
— |
— |
(9 |
) | — |
(9 |
) | |||||||||||||
Intercompany notes payable |
— |
(214 |
) | 56 |
158 |
— |
||||||||||||||
Other, net |
(4 |
) | — |
104 |
— |
100 |
||||||||||||||
Net cash used by financing activities |
(4 |
) | (634 |
) | (477 |
) | 158 |
(957 |
) | |||||||||||
Effect of exchange rate changes on cash, cash equivalents and restricted |
— |
— |
(30 |
) | — |
(30 |
) | |||||||||||||
Net change in cash, cash equivalents and restricted cash |
— |
(936 |
) | 78 |
— |
(858 |
) | |||||||||||||
Cash, cash equivalents and restricted cash at beginning of period |
— |
1,461 |
1,880 |
— |
3,341 |
|||||||||||||||
Cash, cash equivalents and restricted cash at end of period |
— |
525 |
1,958 |
— |
2,483 |
|||||||||||||||
Less cash, cash equivalents and restricted cash of discontinued operations at |
— |
— |
— |
— |
— |
|||||||||||||||
Cash, cash equivalents and restricted cash of continuing operations at |
$ | — |
$ | 525 |
$ | 1,958 |
$ | — |
$ | 2,483 |
||||||||||
(Amounts in millions) |
Parent Guarantor |
Issuer |
All Other Subsidiaries |
Eliminations |
Consolidated |
|||||||||||||||
Cash flows from operating activities: |
||||||||||||||||||||
Net income (loss) |
$ | 343 |
$ | (142 |
) | $ | 872 |
$ | (543 |
) | $ | 530 |
||||||||
Less (income) loss from discontinued operations, net of taxes |
— |
140 |
(151 |
) | — |
(11 |
) | |||||||||||||
Adjustments to reconcile net income (loss) to net cash from operating activities: |
||||||||||||||||||||
Equity in income from subsidiaries |
(366 |
) | (177 |
) | — |
543 |
— |
|||||||||||||
Dividends from subsidiaries |
250 |
1,352 |
(1,602 |
) | — |
— |
||||||||||||||
Amortization of fixed maturity securities discounts and premiums |
— |
8 |
(126 |
) | — |
(118 |
) | |||||||||||||
Net investment (gains) losses |
— |
5 |
(55 |
) | — |
(50 |
) | |||||||||||||
Charges assessed to policyholders |
— |
— |
(699 |
) | — |
(699 |
) | |||||||||||||
Acquisition costs deferred |
— |
— |
(27 |
) | — |
(27 |
) | |||||||||||||
Amortization of deferred acquisition costs and intangibles |
— |
— |
441 |
— |
441 |
|||||||||||||||
Deferred income taxes |
1 |
132 |
6 |
— |
139 |
|||||||||||||||
Derivative instruments and limited partnerships |
— |
(35 |
) | (63 |
) | — |
(98 |
) | ||||||||||||
Stock-based compensation expense |
26 |
— |
1 |
— |
27 |
|||||||||||||||
Change in certain assets and liabilities: |
||||||||||||||||||||
Accrued investment income and other assets |
— |
7 |
(365 |
) | — |
(358 |
) | |||||||||||||
Insurance reserves |
— |
— |
1,259 |
— |
1,259 |
|||||||||||||||
Current tax liabilities |
16 |
(43 |
) | 53 |
— |
26 |
||||||||||||||
Other liabilities, policy and contract claims and other policy-related balances |
(17 |
) | (44 |
) | 668 |
2 |
609 |
|||||||||||||
Cash from operating activities—discontinued operations |
— |
134 |
275 |
— |
409 |
|||||||||||||||
Net cash from operating activities |
253 |
1,337 |
487 |
2 |
2,079 |
|||||||||||||||
Cash flows from (used by) investing activities: |
||||||||||||||||||||
Proceeds from maturities and repayments of investments: |
||||||||||||||||||||
Fixed maturity securities |
— |
— |
3,436 |
— |
3,436 |
|||||||||||||||
Commercial mortgage loans |
— |
— |
582 |
— |
582 |
|||||||||||||||
Restricted commercial mortgage loans related to a securitization entity |
— |
— |
15 |
— |
15 |
|||||||||||||||
Proceeds from sales of investments: |
||||||||||||||||||||
Fixed maturity and equity securities |
— |
— |
3,883 |
— |
3,883 |
|||||||||||||||
Purchases and originations of investments: |
||||||||||||||||||||
Fixed maturity and equity securities |
— |
— |
(6,899 |
) | — |
(6,899 |
) | |||||||||||||
Commercial mortgage loans |
— |
— |
(813 |
) | — |
(813 |
) | |||||||||||||
Other invested assets, net |
— |
5 |
(392 |
) | (2 |
) | (389 |
) | ||||||||||||
Policy loans, net |
— |
— |
62 |
— |
62 |
|||||||||||||||
Intercompany notes receivable |
(119 |
) | 48 |
6 |
65 |
— |
||||||||||||||
Capital contributions to subsidiaries |
(5 |
) | — |
5 |
— |
— |
||||||||||||||
Proceeds from sale of business, net of cash transferred |
— |
— |
1,398 |
— |
1,398 |
|||||||||||||||
Cash from investing activities—discontinued operations |
— |
— |
26 |
— |
26 |
|||||||||||||||
Net cash from (used by) investing activities |
(124 |
) | 53 |
1,309 |
63 |
1,301 |
||||||||||||||
Cash flows used by financing activities: |
||||||||||||||||||||
Deposits to universal life and investment contracts |
— |
— |
824 |
— |
824 |
|||||||||||||||
Withdrawals from universal life and investment contracts |
— |
— |
(2,319 |
) | — |
(2,319 |
) | |||||||||||||
Repayment and repurchase of long-term debt |
— |
(446 |
) | — |
— |
(446 |
) | |||||||||||||
Intercompany notes payable |
(122 |
) | 112 |
75 |
(65 |
) | — |
|||||||||||||
Repurchase of subsidiary shares |
— |
— |
(22 |
) | — |
(22 |
) | |||||||||||||
Dividends paid to noncontrolling interests |
— |
— |
(87 |
) | — |
(87 |
) | |||||||||||||
Other, net |
(7 |
) | (24 |
) | (4 |
) | — |
(35 |
) | |||||||||||
Cash used by financing activities—discontinued operations |
— |
— |
(132 |
) | — |
(132 |
) | |||||||||||||
Net cash used by financing activities |
(129 |
) | (358 |
) | (1,665 |
) | (65 |
) | (2,217 |
) | ||||||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash (includes $6 related to discontinued operations) |
— |
— |
1 |
— |
1 |
|||||||||||||||
Net change in cash, cash equivalents and restricted cash |
— |
1,032 |
132 |
— |
1,164 |
|||||||||||||||
Cash, cash equivalents and restricted cash at beginning of period |
— |
429 |
1,748 |
— |
2,177 |
|||||||||||||||
Cash, cash equivalents and restricted cash at end of period |
— |
1,461 |
1,880 |
— |
3,341 |
|||||||||||||||
Less cash, cash equivalents and restricted cash of discontinued operations at end of period |
— |
— |
— |
— |
— |
|||||||||||||||
Cash, cash equivalents and restricted cash of continuing operations at end of period |
$ | — |
$ | 1,461 |
$ | 1,880 |
$ | — |
$ | 3,341 |
||||||||||
Item 3. |
Quantitative and Qualitative Disclosures About Market Risk |
Item 4. |
Controls and Procedures |
Item 1. |
Legal Proceedings |
Item 1A. |
Risk Factors |
Item 6. |
Exhibits |
Number |
Description | |||
2.1 |
||||
31.1 |
||||
31.2 |
||||
32.1 |
||||
32.2 |
||||
101.INS |
XBRL Instance Document | |||
101.SCH |
XBRL Taxonomy Extension Schema Document | |||
101.CAL |
XBRL Taxonomy Extension Calculation Linkbase Document | |||
101.LAB |
XBRL Taxonomy Extension Label Linkbase Document | |||
101.PRE |
XBRL Taxonomy Extension Presentation Linkbase Document | |||
101.DEF |
XBRL Taxonomy Extension Definition Linkbase Document | |||
104 |
The cover page for the Company’s Quarterly Report on Form 10-Q for the three months ended March 31, 2020, has been formatted in Inline XBRL |
GENWORTH FINANCIAL, INC. (Registrant) | ||||||
Date: May 6, 2020 |
||||||
By: |
/s/ Matthew D. Farney | |||||
Matthew D. Farney Vice President and Controller (Principal Accounting Officer) |